|
|---|
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-140 | CAN BLOOD DONOR RESEARCH INFORM THE EPIDEMIOLOGY OF EARLY METABOLIC DYSFUCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)? | Sheila O'Brien |
| CLM | Other liver disease - Biomedical, Translational & Basic Science | P-019 | MACROPHAGE HETEROGENEITY AND INTERACTIONS WITH T CELLS IN HUMAN HEPATOCELLULAR CARCINOMA REVEALED BY SINGLE CELL AND SPATIAL TRANSCRIPTOMICS | Jawairia Atif |
| CDDW | Neurogastroenterology & Motility | A324 | FECAL MICROBIOTA TRANSPLANTATION FOR SYMPTOM IMPROVEMENT IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS | Natsuda Aumpan |
| CDDW | Intestinal Disorder | A86 | REAL LIFE DIAGNOSTIC ACCURACY OF HIGH-RESOLUTION ANORECTAL MANOMETRY FOR THE DIAGNOSIS OF HIRSCHSPRUNG’S DISEASE IN CHILDREN | Marijke Awouters |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-79 | FEASIBILITY AND EARLY EXPERIENCE OF A NOVEL INTERDICIPILINARY ALCOHOL-ASSOCIATED LIVER DISEASE CLINIC | Amirhossein Azhie |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-125 | ASSESSING THE IMPACT OF DEMOGRAPHIC, METABOLIC AND LIVER DISEASE SEVERITY FACTORS ON PHYSICAL AND MENTAL HEALTH COMPOSITE SCORES AMONG A LARGE CANADIAN MASLD COHORT | Elizabeth Baguley |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-126 | EVALUATING THE ASSOCIATION OF PATIENT CHARACTERISTICS ON EMERGENCY DEPARTMENT USE AMONG A COHORT OF CANADIAN MASLD PATIENTS IN PRIMARY CARE | Elizabeth Baguley |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-127 | EVALUATING THE ASSOCIATION OF PATIENT CHARACTERISTICS ON HOSPITALIZATIONS AMONG A COHORT OF CANADIAN MASLD PATIENTS IN PRIMARY CARE | Elizabeth Baguley |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-42 | ASSOCIATION BETWEEN CORTICAL ATROPHY AND HEPATIC ENCEPHALOPATHY IN CRITICALLY ILL PATIENTS WITH DECOMPENSATED CIRRHOSIS | Luis Bagulho |
| CDDW | Cellular & Molecular Gastroenterology | A19 | MICROBIOTA-MEDIATED IMPACT OF CHRONIC STRESS ON INTESTINAL CRYPT STEM-CELL CYCLING AND PANETH-CELL PROLIFERATION | Xiaopeng Bai |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A209 | CONNECTING ADVERSE FOOD REACTION TO GUT INFLAMMATION: DISRUPTION OF MICROBIAL METABOLISM BY GUT INFLAMMATION DRIVES ADVERSE FOOD REACTIONS | Bruna Barbosa da Luz |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-105 | NAVIGATING HCV TREATMENT DECISION-MAKING DURING PREGNANCY: A QUALITATIVE STUDY | Tamara Barnett |
| CDDW | Gastrointestinal Oncology | A177 | PARP1 LACTYLATION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA LINKS CELL METABOLISM AND GENOME STABILITY | Camille Bazin |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A254 | HETEROGENEITY OF DISEASE LOCATION IN RANDOMIZED, PLACEBO-CONTROLLED PHARMACEUTICAL TRIALS (RCTS) IN INFLAMMATORY BOWEL DISEASE (IBD) | Abigaile Beamish |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A260 | INVESTIGATING THE ROLE OF MICROBIAL PROTEIN METABOLISM ACROSS DEFINED MICROBIOTA MOUSE MODELS AND INFLAMMATORY CONDITIONS | Kayla Beaudoin |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-023 | PREDICTORS OF READMISSION AND LONG-TERM SURVIVAL IN DECOMPENSATED CIRRHOSIS: A RETROSPECTIVE CANADIAN MULTICENTRE COHORT STUDY | Adedamola Bello |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A250 | PRECLINICAL CROHN’S DISEASE IS MARKED BY YEAST EXPANSION AND LOSS OF FILAMENTOUS FUNGI | Biju Bharali |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-97 | PHARMACIST-LED HEPATITIS C DIAGNOSIS AND RAPID MANAGEMENT - IN COMMUNITY (PHARM-C): A PHASE IV NONBLINDED RANDOMIZED CONTROLLED TRIAL | Mia Biondi |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A277 | COMPARISON OF PATIENT RESPONSE TO FIRST VERSUS SECOND-LINE INFLIXIMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS: A RETROSPECTIVE STUDY | Dorota Borovsky |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A252 | THE EFFECT OF LACTICASEIBACILLUS RHAMNOSUS STRAIN C51 IN THE PREVENTION OF COLITIS IN HIGH PROTEOLYTIC IBD MICROBIOTA COLONIZED MICE | Brooke Bowerman |
| CDDW | Pancreas | A316 | THE IMPACT OF SOCIOECONOMIC AND DEMOGRAPHIC FACTORS ON TREATMENT OUTCOMES IN PATIENTS WITH PANCREATIC FLUID COLLECTIONS | Gurmun Brar |
| CDDW | Gastrointestinal Oncology | A172 | OPTIMIZING THE FECAL IMMUNOCHEMICAL TEST (FIT) POSITIVITY THRESHOLD IN THE NOVA SCOTIA COLON CANCER PREVENTION PROGRAM (CCPP) | Scott Bray |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A267 | A REAL-WORLD CANADIAN RETROSPECTIVE STUDY OF DRUG PERSISTENCE OF MIRIKIZUMAB IN ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS | Marta Braun |
| CDDW | Clinical Practice | A142 | EXAMINING FACTORS CONTRIBUTING TO GENDER PAY DIFFERENCES AMONG ONTARIO PHYSICIANS IN SUBSPECIALTIES OF INTERNAL MEDICINE, INCLUDING GASTROENTEROLOGY - AN UPDATE | Maham Bushra |
| CDDW | Neurogastroenterology & Motility | A330 | SLEEP QUALITY AS MEDIATING FACTOR BETWEEN ADVERSE CHILDHOOD EXPERIENCES AND IBS SYMPTOM SEVERITY: AN EXPLORATORY STUDY | Stephanie Busse |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A296 | IMPACT OF INFLAMMATORY BOWEL DISEASE ON ANXIETY AND DEPRESSION DURING PREGNANCY: A RETROSPECTIVE SURVEY STUDY | Nikhila Butani |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A297 | CULTURALLY RELEVANT DIETARY RECOMMENDATIONS IN IBD - AN UNMET NEED | Justin Buttar |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-34 | BRIDGING CRITICALLY ILL PATIENTS WITH CIRRHOSIS TO TRANSPLANT WITH RENAL REPLACEMENT THERAPY: A MULTICENTER COHORT STUDY | Filipe Cardoso |
| CDDW | Intestinal Disorder | A81 | SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN PATIENTS WITH NON-RESPONSIVE CELIAC DISEASE ATTENDING THE MCMASTER ADULT CELIAC CLINIC | Griffin Carr |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A301 | THE CLINICAL COURSE AND MAGNETIC RESONANCE IMAGING FINDINGS IN ISOLATED PERIANAL CROHN’S DISEASE | Jason Chambers |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A200 | EVALUATION OF PERIPHERAL ABSOLUTE EOSINOPHIL COUNT AS A BIOMARKER OF DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS | Katherine Chan |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-41 | ESTABLISHING QUALITY MEASURES FOR THE MANAGEMENT OF ASCITES IN ALBERTA: RESULTS FROM A POPULATION-BASED COHORT STUDY | Leona Chan |
| CDDW | Gastrointestinal Oncology | A174 | EXCEPTIONALLY RARE CASE OF RECTAL METASTASIS IN EARLY STAGE LUNG ADENOCARCINOMA | Nicole Chang |
| CDDW | Intestinal Disorder | A79 | A PILOT RANDOMIZED CONTROLLED TRIAL TO EVALUATE EFFECT OF LATE VS EARLY INTRODUCTION OF GLUTEN-FREE OATS ON SYMPTOMATIC, SEROLOGIC AND DISEASE ACTIVITY IN PATIENTS WITH NEWLY DIAGNOSED CELIAC DISEASE | Nicole Chang |
| CDDW | Clinical Practice | A93 | THE LONGER THE WAIT, THE GREATER THE RISK: A META-ANALYSIS OF SURVEILLANCE INTERVALS FOR PATIENTS AFTER RESECTION OF 1-2 SMALL NON-ADVANCED ADENOMAS | Nicole Chang |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-139 | VALIDATION OF THRESHOLDS FOR FIB-4 IN THREE DIFFERENT AGE GROUPS TO RISK STRATIFY PATIENTS WITH LIVER FIBROSIS | Sukhdeep Cheema |
| CDDW | Clinical Practice | A148 | ELECTRONIC CONSULTATION AND REFERRAL SERVICE IS SAFE AND REDUCES THE NEED FOR TERTIARY EVALUATIONS FOR DISORDERS OF GUT-BRAIN INTERACTION IN CHILDREN | Biqi Chen |
| CDDW | Clinical Practice | A151 | PILOT VIRTUAL EDUCATIONAL WEBSITE FOR PEDIATRIC DISORDERS OF GUT-BRAIN INTERACTION | Biqi Chen |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A220 | BREASTFEEDING PRACTICES IN MOTHERS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY | Sherry Chen |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A230 | CHILDHOOD EXPOSURE TO A SIBLING WITH CROHN'S DISEASE ALTERS GUT MICROBIOME AND INCREASES DISEASE SUSCEPTIBILITY | Rirong Chen |
| CDDW | Cellular & Molecular Gastroenterology | A43 | GUT–BREAST AXIS: DIETARY FLAXSEED MODIFIES MICROBIOTA–MAMMARY MICRORNA NETWORKS LINKED TO BREAST CANCER IN AN INTESTINAL REGION-SPECIFIC MANNER | Yue-Tong Chen |
| CDDW | Clinical Practice | A100 | IMPACT OF GLP-1 RECEPTOR AGONISTS ON THE QUALITY OF BOWEL PREPARATION IN SCREENING COLONOSCOPIES | Edwin Cheng |
| CDDW | Liver | A181 | DEVELOPMENT OF AN IMPLEMENTABLE MULTIMODAL ARTIFICIAL INTELLIGENCE (AI) TOOL TO PREDICT HISTOLOGICAL RESPONSE IN LIVER TRANSPLANT RECIPIENTS WITH REJECTION | Anu Chinnadurai |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-7 | YOUNG ADULT AUTOIMMUNE LIVER DISEASE: A SINGLE CENTRE EVALUATION CENTRED ON PRIMARY SCLEROSING CHOLANGITIS AND ITS AUTOIMMUNE HEPATITIS VARIANT | Anu Chinnadurai |
| CDDW | Clinical Practice | A118 | TREATMENT OF IDIOPATHIC DIABETIC DIARRHEA: A SYSTEMATIC REVIEW | Rosalind Cho |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A271 | REAL-WORLD EFFECTIVENESS OF ABP-654 IN PATIENTS WITH INFLAMATORY BOWEL DIESEASE IN CANADA | Manprit Chohan |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-92 | COLLABORATION BETWEEN RESEARCHERS AND COMMUNITY ON QUANTITATIVE VIRAL HEPATITIS RESEARCH: LESSONS FROM COMMUNITY ENGAGEMENT IN VANCOUVER’S DOWNTOWN EASTSIDE | JiHyun Choi |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-36 | DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING TOOL TO PREDICT RISK OF RENAL DYSFUNCTION IN LIVER TRANSPLANT PATIENTS | Joseph Chon |
| CDDW | Clinical Practice | A103 | THE RISK OF VENOUS THROMBOEMBOLISM BY PHASE OF CARE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | Jocelyn Chow |
| CDDW | Clinical Practice | A117 | IMPACT OF PATIENT AND PHYSICIAN GENDER ON PHYSICIAN ASSESSMENT OF IBD REFERRALS | Jocelyn Chow |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A307 | A SYSTEMATIC REVIEW OF THE EFFECTIVENESS AND SAFETY OF SEQUENTIAL RESCUE THERAPY WITH JAK INHIBITORS IN ACUTE SEVERE ULCERATIVE COLITIS | Amber Cintosun |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A289 | TUBULOINTERSTITIAL NEPHRITIS: A RARE EXTRA-INTESTINAL MANIFESTATION OF INFLAMMATORY BOWEL DISEASE | Alexandra Cohen |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-37 | FROM CHILDHOOD TO ADULTHOOD: OUTCOMES AFTER PEDIATRIC LIVER TRANSPLANTATION WITH A MEDIAN 25-YEAR FOLLOW-UP | Julia Collot |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A203 | OPTIMIZING CARE: DISCONTINUING EMPIRIC PROTON PUMP INHIBITORS IN PATIENTS WITHOUT EVIDENCE OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) | Kyle Comishen |
| CDDW | Clinical Practice | A110 | TRENDS IN SPENDING ON ADVANCED IBD THERAPIES PRESCRIBED BY GASTROENTEROLOGISTS IN MEDICARE | Stephen Congly |
| CDDW | Clinical Practice | A106 | PREVALENCE AND HEALTH CARE ENGAGEMENT FOR INFLAMMATORY BOWEL DISEASE PATIENTS IN THE EDMONTON ZONE: PAST, PRESENT, AND FUTURE | Jared Cooper |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A211 | THE INCIDENCE AND PREVALENCE OF PEDIATRIC INFLAMMATORY BOWEL DISEASE IN NINE NATIONS ACROSS THE GLOBE: AN ANALYSIS OF THE 3RD EPIDEMIOLOGIC STAGE | Stephanie Coward |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-029 | EXPLORING PATIENT PERSPECTIVES ON A DIGITALLY DELIVERED PREHABILITATION PROGRAM IN PATIENTS WITH CIRRHOSIS AWAITING LIVER TRANSPLANTATION | Christofer Cruz |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-43 | UNDERSTANDING THE SPECTRUM OF “ONCO-HEPATOLOGY” IN CANADA | Morven Cunningham |
| CDDW | Neurogastroenterology & Motility | A328 | INFLUENCE OF IN UTERO CANNABIS SMOKE EXPOSURE ON FETAL GUT-BRAIN AXIS DEVELOPMENT | Sierra D'Amico |
| CDDW | Clinical Practice | A113 | PRACTICES AND PERCEPTIONS OF ADVANCED ENDOSCOPIC IMAGING TECHNIQUES FOR COLORECTAL NEOPLASIA DETECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SURVEY AMONG CANADIAN IBD SPECIALISTS | Rebecca Dang |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-78 | GENDER DIFFERENCES IN DIRECT-ACTING ANTIVIRAL UPTAKE BEFORE, DURING AND AFTER THE COVID-19 PANDEMIC AMONG HIV-HCV CO-INFECTED INDIVIDUALS IN CANADA | Aïché Danioko |
| CDDW | Gastrointestinal Oncology | A175 | COMPARATIVE ANALYSIS OF RESIDUAL NEOPLASIA AND PROCEDURAL OUTCOMES IN CURATIVE VERSUS NON-CURATIVE COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION | Franco D'Anna |
| CDDW | Endoscopy, Technology & Imaging | A70 | CANADIAN EXPERIENCE WITH ENDOSCOPIC ULTRASOUND-GUIDED GASTROJEJUNOSTOMY: A CASE SERIES | Ali Dashti |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-119 | INDEPENDENT ASSOCIATION BETWEEN VITAMIN D INSUFFICIENCY AND LIVER FIBROSIS IN PEOPLE WITH HIV, REGARDLESS OF STEATOTIC LIVER DISEASE OR HEPATITIS C COINFECTION | Aurgho Datta |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A221 | A SYSTEMATIC REVIEW OF DEFINITIONS AND DIAGNOSIS OF CROHN’S DISEASE COLONIC STRICTURES | Ravdip Dhaliwal |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A263 | INTESTINAL EPITHELIAL CELL-SPECIFIC DELETION OF JAK2 DISRUPTS GUT HOMEOSTASIS AND INCREASES INTESTINAL PERMEABILITY | Brooke D'Mello |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A190 | A PROSPECTIVE APPROACH TO TREATMENT RESPONSE IN EOSINOPHILIC ESOPHAGITIS IN ALBERTA | Poshika Dhingra |
| CDDW | Clinical Practice | A138 | FREQUENCY OF ENDOSCOPIC REASSESSMENT FOLLOWING ADVANCED THERAPY INITIATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | David Di Fonzo |
| CDDW | Obesity, Metabolism & Nutrition | A90 | INVESTIGATING THE ROLE OF OREXIN SIGNALING IN IMPAIRED SATIETY SENSING IN OBESITY. | Olivia DiPaolo |
| CDDW | Endoscopy, Technology & Imaging | A54 | HUMAN-MACHINE INTERACTION IN OPTICAL POLYP DIAGNOSIS: DECISION-MAKING AFTER CADX POLYP DIAGNOSIS | Delphine Dubois |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A202 | COMPARISON OF INVASIVE HELICOBACTER PYLORI DETECTION METHODS IN PATIENTS UNDERGOING GASTROSCOPY IN A CANADIAN TERTIARY CARE CENTER. | James Duerksen |
| CDDW | Intestinal Disorder | A84 | SOCIOECONOMIC FACTORS AND SYMPTOM BURDEN IN CELIAC DISEASE: RESULTS OF A NATIONWIDE CANADIAN SURVEY | Donald Duerksen |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-108 | REFRACTORY PEDIATRIC AUTOIMMUNE HEPATITIS AND B-CELL DEPLETION THERAPY: A CASE REPORT | Rohil Dureja |
| CDDW | Clinical Practice | A126 | HEALTH BEHAVIOUR CHANGE IN IBD: MAPPING READINESS, MOBILE HEALTH PREFERENCES, AND ENGAGEMENT | Max Eisele |
| CDDW | Clinical Practice | A149 | EMPOWEREMENT IN THE PALM OF YOUR HAND: IBS PATIENT PERSPECTIVES ON A MOBILE APP WITH HEALTH COACHING | Max Eisele |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-11 | PHENOTYPE AND OUTCOMES OF PSC–IBD IN NOVA SCOTIA: A SINGLE-CENTRE RETROSPECTIVE COHORT | Mohamed Eissa |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-86 | BARRIERS AND FACILITATORS TO IMPLEMENTING POINT-OF-CARE TESTING FOR SEXUALLY TRANSMITTED AND BLOOD-BORNE INFECTIONS: PRELIMINARY FINDINGS FROM A MIXED-METHODS SYSTEMATIC REVIEW | Daniel Elakpa |
| CDDW | Clinical Practice | A120 | PRELIMINARY RESULTS ON THE FEASIBILITY AND ACCEPTABILITY OF A MENTAL HEALTH PATHWAY FOR IBD | Brady Elchitz |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-57 | UPFRONT LAPAROSCOPIC CHOLECYSTECTOMY VERSUS PREOPERATIVE MRCP OR ERCP IN PATIENTS WITH SUSPECTED CHOLEDOCHOLITHIASIS | Irem Engin |
| CDDW | Obesity, Metabolism & Nutrition | A92 | NUTRITIONAL OPTIMIZATION TO REDUCE COMPLICATIONS FOLLOWING SURGERY FOR CROHN’S DISEASE: A QUALITY IMPROVEMENT PROJECT | Onyinyechukwu Esenwa |
| CDDW | Endoscopy, Technology & Imaging | A65 | RETROSPECTIVE ANALYSIS OF OUTCOMES AFTER TRANSCATHETER ARTERIAL ANGIOEMBOLIZATION IN PATIENTS WITH NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING | Muhammad Anas Fazal |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A191 | DIAGNOSTIC UTILITY OF THE CARS SCORE FOR ACHALASIA: INTEGRATING ENDOSCOPIC FINDINGS INTO DYSPHAGIA PATHWAYS | Mashal Fida |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-60 | REFRACTORY BRONCHOBILIARY FISTULA AFTER HEPATIC ABLATION: INFECTION-DRIVEN RECURRENCE DESPITE MULTIMODAL CLOSURE | Mashal Fida |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A294 | DEVELOPMENT OF A MACHINE LEARNING MODEL FOR THE USE OF BLOOD BIOMARKERS TO PREDICT IBD PRESENCE AND ACTIVITY | Kyra Fine |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A305 | CHARCATERIZATION OF RESPONSE PHENOTYPES FOR MOLECULAR TARGETED THERAPIES IN CROHN'S DISEASE | Elliot Fortin |
| CLM | MASLD/MASH – Biomedical, Translational & Basic Science | P-114 | SEX AND POST–LIVER TRANSPLANT OUTCOMES: NO ASSOCIATION WITH HEPATIC STEATOSIS, GRAFT REJECTION, SURVIVAL, OR FOLLOW-UP ADHERENCE IN 608 RECIPIENTS | Thierry FotsingTadjo |
| CDDW | Clinical Practice | A108 | SAME-DAY DISCHARGE AFTER THIRD-SPACE ENDOSCOPY: A SYSTEMATIC REVIEW AND META-ANALYSIS | Mary Raina Angeli Fujiyoshi |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A214 | IN UTERO EXPOSURE TO BIOLOGIC THERAPIES AND EARLY INFANT HEALTH OUTCOMES AMONG CHILDREN BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY | Chun Yiu Jordan Fung |
| CDDW | Clinical Practice | A109 | REPRODUCTIVE CARE DURING PRECONCEPTION AND PREGNANCY IN INFLAMMATORY BOWEL DISEASE (IBD): IMMIGRANT VS. NON-IMMIGRANT PERSPECTIVES | Christiane Gafrey |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-45 | NON-HEPATIC SURGICAL OUTCOMES AMONG ADULTS WITH LIVER CIRRHOSIS IN NOVA SCOTIA: A POPULATION-BASED COHORT STUDY | Patrick Gallagher |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-66 | PKR: AN UNEXPECTED ALLY OF HEPATITIS C VIRUS | Carla Gallardoflores |
| CDDW | Clinical Practice | A132 | IMPLICATIONS OF ARTIFICIAL INTELLIGENCE FOR THE FORMAL AND HIDDEN CURRICULUM IN GASTROENTEROLOGY TRAINING | Ciaran Galts |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A217 | SECOND-LINE INFLIXIMAB THERAPY FOR CROHN'S DISEASE (SLIT-CD): A RETROSPECTIVE COHORT STUDY | Ciaran Galts |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A298 | CASE REPORT: SINGLE DOSE OF INFLIXIMAB AND RISK OF ANTIBODIES | Ciaran Galts |
| CDDW | Liver | A180 | MULTI-OMIC PROFILING REVEALS CHANGES IN HEPATIC TRANSCRIPTOME, METABOLOME, AND MICROBIOME ASSOCIATED WITH IMPROVEMENT IN HISTOLOGY AT 12 MONTHS POST ROUX-EN-Y GASTRIC BYPASS | Yasaman Ghorbani |
| CLM | Other liver disease - Biomedical, Translational & Basic Science | P-018 | LIPID METABOLISM REPROGRAMMING IN DT81HEPA1-6 MURINE HEPATOCELLULAR CARCINOMA CELLS | Héloïse Giudicelli |
| CDDW | Intestinal Disorder | A78 | RISK OF CELIAC DISEASE AUTOIMMUNITY FROM EARLY-LIFE INFECTIONS AND ANTIMICROBIAL USE: A 10-YEAR RETROSPECTIVE BIRTH COHORT STUDY | Quinn Goddard |
| CDDW | Cellular & Molecular Gastroenterology | A28 | MUCUS FROM A HYPERSECRETORY MUTANT GOBLET-LIKE CELL INCREASES ENTAMOEBA HISTOLYTICA VIRULENCE AND CYTOTOXICITY | Hayley Gorman |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A248 | DIETARY CARRAGEENANS FUEL INFLAMMATION AND IMPAIR EPITHELIAL BARRIER IN SELECT INFLAMMATORY BOWEL DISEASE PATIENTS | Hayley Gorman |
| CDDW | Clinical Practice | A133 | REAL WORLD EFFICACY OF GLP-2 AGONISTS IN PEDIATRIC INTESTINAL FAILURE: CANADIAN NATIONAL MULTICENTRE CASE SERIES | Anja Greaves |
| CLM | Other liver disease - Biomedical, Translational & Basic Science | P-149 | MITOCHONDRIAL COMPLEX I DYSFUNCTION AND DMAC2 DOWNREGULATION AS EARLY DRIVERS OF HEPATOCELLULAR CARCINOMA | Wen Gu |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A235 | FROM PLATE TO GUT: AGE-DEPENDENT EFFECTS OF DIETARY LIPIDS AND GUT MICROBIOTA ON CROHN’S DISEASE RISK | Fredy Guevara Agudelo |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A283 | USE OF FECAL CALPROTECTIN AND INTESTINAL ULTRASOUND FOR EVALUATION OF INFLAMMATION IN FIBROSTENOTIC CROHN’S DISEASE | Vishrut Gulhati |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A268 | SYSTEMATIC REVIEW OF APPENDICEAL CROHN'S DISEASE: DIAGNOSIS AND MANAGEMENT | Iris Guo |
| CDDW | Clinical Practice | A143 | ANTIPLATELET THERAPY FOR THE PREVENTION OF GI DISEASE: AN UMBRELLA REVIEW | Arnav Gupta |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A199 | A SYSTEMATIC REVIEW: ROLE OF PYLORIC DILATION IN THE MANAGEMENT OF GASTROPARESIS | Milli Gupta |
| CDDW | Cellular & Molecular Gastroenterology | A31 | ORAL MICROBIAL DEGRADATION OF FOOD ALLERGENS: IMPLICATIONS FOR PEANUT AND COW’S MILK ALLERGY | Peter Hall |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-135 | ASSESSMENT OF PATIENT SATISFACTION AT TERTIARY CENTER NURSE-LED MASLD CLINICS. | Nashla HamdanPerez |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-136 | ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK IS ASSOCIATED WITH STEATOSIS IN MASLD PATIENTS | Nashla HamdanPerez |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-146 | OBSERVATIONAL STUDY ON CHARACTERISTICS OF LEAN VERSUS OVERWEIGHT PERSONS WITH MASLD | Nashla HamdanPerez |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-44 | HEALTH CARE PROVIDERS ENGAGEMENT WITH A CLINICAL DECISION SUPPORT TOOL TO ENHANCE RECOGNITION OF CSPH AND APPROPRIATE USE OF NSBB THERAPY | Nashla HamdanPerez |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-100 | TIMELINES FOR APPROVAL OF HEPATITIS B AND C THERAPIES: COMPARISON BETWEEN HEALTH CANADA, THE EUROPEAN MEDICINES AGENCY, AND THE FOOD AND DRUG ADMINISTRATION | Patrick Hamilton |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A195 | COMBINING SYMPTOMS AND ENDOSCOPIC FINDINGS TO PREDICT GERD DIAGNOSED BY 24-HOUR PH MONITORING | Yifan Han |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A227 | BRAIN NEAR INFRARED SPECTROSCOPY REVEALS A POTENTIAL LINK BETWEEN PREFRONTAL CORTEX HYPOXIA, MITOCHONDRIAL DYSFUNCTION, AND ALTERED INTEROCEPTION IN CROHN'S DISEASE | Ayden Hansen |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A312 | MENTAL HEALTH BURDEN OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT CHUS SHERBROOKE IN THE AFTERMATH OF THE COVID-19 PANDEMIC | Oumkaltoum Harati |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-84 | SEXUALISED DRUG USE AMONG PEOPLE WHO INJECT DRUGS IN MONTREAL, CANADA - IMPLICATIONS FOR BLOOD BORNE VIRUS PREVENTION | Brendan Harney |
| CDDW | Clinical Practice | A95 | RESULTS OF A PROACTIVE REMOTE MONITORING QUALITY IMPROVEMENT (QI) INITIATIVE FOR PREGNANT PEOPLE WITH IBD | Meghan Harris |
| CDDW | Obesity, Metabolism & Nutrition | A87 | CROHN'S DISEASE THERAPEUTIC DIET INTERVENTION IMPROVES INTESTINAL PERMEABILITY | Natasha Haskey |
| CLM | ALD - Clinical Science, Epidemiology & Public Health | P-4 | TEMPORAL TRENDS AND SEASONALITY OF ALCOHOL SALES IN RELATION TO ALCOHOL-RELATED LIVER DISEASE HOSPITALIZATIONS IN ALBERTA, CANADA | Liam Swain |
| CLM | ALD - Clinical Science, Epidemiology & Public Health | P-003 | SOCIODEMOGRAPHIC DRIVERS LINKING ALCOHOL SALES AND NEW HOSPITALIZATIONS FOR ALCOHOL-RELATED HEPATITIS IN ALBERTA, CANADA | Liam Swain |
| CDDW | Neurogastroenterology & Motility | A332 | AGE AND SEX INFLUENCE ESOPHAGEAL SYMPTOMS IN REFLUX-NEGATIVE PATIENTS WITH NORMAL ESOPHAGEAL MOTILITY | Ramey Kharfan |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-026 | A MULTIMODAL AI TOOL INTEGRATING IMAGING AND CLINICAL DATA FOR DIAGNOSIS OF CLINICAL GRAFT FIBROSIS AFTER LIVER TRANPLANTATION | Annabel Koivu |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-47 | A NOVEL FOUNDER MUTATION IN HEMOJUVELIN IDENTIFIED IN AN INDIGENOUS NORTHERN ALBERTAN POPULATION LEADING TO TYPE 2A JUVENILE HEMOCHROMATOSIS | Scott MacKay |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-58 | ACUTE CHOLANGITIS DUE TO PIGMENT STONES IN A PATIENT WITH SICKLE CELL ANEMIA: A HEMOLYSIS DRIVEN BILIARY COMPLICATION | Ninoska Melendez |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A280 | AN ANALYSIS OF LONG TERM OUTCOMES IN CROHN’S PATIENTS POST–BALLOON ASSISTED ENDOSCOPIC STRICTURE DILATION: FACTORS ASSOCIATED WITH SURGERY AND A NEW PREDICTIVE MODEL | Kunihiko Oguro |
| CDDW | Gastrointestinal Oncology | A163 | A COLORECTAL CANCER-ASSOCIATED FECAL MIRNOME AND ITS POTENTIAL TO ALTER FUSOBACTERIUM NUCLEATUM AND ESCHERICHIA COLI GENE EXPRESSION | Jiali Pan |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-30 | ACCURACY OF DIETARY INTAKE ESTIMATION IN PATIENTS WITH CIRRHOSIS BEING ASSESSED FOR LIVER TRANSPLANTATION | Danielle Picard |
| CDDW | Cellular & Molecular Gastroenterology | A37 | ACTIVATED B CELL RESPONSES IN THE COLON OF ULCERATIVE COLITIS PATIENTS AND MOUSE MODEL OF COLITIS | Milad Sabzevary |
| CDDW | Gastrointestinal Oncology | A165 | 5-FU RESISTANT COLON CANCER ORGANOIDS, A GREAT TOOL TO DEMYSTIFY THE INTERACTION BETWEEN CANCER STEM CELLS AND CANCER-ASSOCIATED FIBROBLASTS | Molly Sedeuil |
| CLM | ALD - Clinical Science, Epidemiology & Public Health | P-5 | ALCOHOL-ASSOCIATED LIVER DISEASE AND CLINICAL OUTCOMES IN LIVER TRANSPLANT CANDIDATES: A CANADIAN SINGLE-CENTER COHORT STUDY | Nimrit Sidhu |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-138 | ALT ALONE FAILS TO IDENTIFY ADULTS WITH TYPE 2 DIABETES AT RISK OF LIVER FIBROSIS: A POPULATION-BASED ANALYSIS OF CONCURRENT AND SEQUENTIAL TESTING | Cindy Wen |
| CDDW | Cellular & Molecular Gastroenterology | A42 | ANTIBIOTICS AND C. DIFFICILE INFECTION DIFFERENTIALLY REGULATE MOUSE INTESTINAL TUFT CELL POPULATIONS | Nada Al-Emadi |
| CDDW | Clinical Practice | A140 | A CHALLENGING CASE OF NON-CIRRHOTIC PORTAL HYPERTENSION IN MYELOPROLIFERATIVE DISEASE: WHEN SPLENECTOMY BECOMES THE SOLUTION. | Ahmed Almohsen |
| CDDW | Neurogastroenterology & Motility | A331 | ANALYSIS OF ESOPHAGEAL CHARACTERISTICS IN CHILDREN WITH ESOPHAGEAL ATRESIA USING FLIP PANOMETRY | Marijke Awouters |
| CDDW | Clinical Practice | A96 | ADHERENCE TO PAST AND CONTEMPORARY POST-POLYPECTOMY SURVEILLANCE GUIDELINES | Alan Barkun |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-104 | ADAPTING AND PIVOTING: TRANSFORMING MICRO-ELIMINATION WITHIN A NURSE-LED HEPATITIS C TREATMENT PROGRAM IN VICTORIA, BC. | Tamara Barnett |
| CDDW | Clinical Practice | A130 | A COHORT REVIEW OF CELIAC PATIENTS WITH NORMAL SEROLOGY. IS FOLLOW-UP EGD INDICATED? | Benedict Blake |
| CDDW | Neurogastroenterology & Motility | A321 | 3D IMAGING UNCOVERS STRUCTURAL ALTERATIONS IN THE MUSCULARIS MACROPHAGES AND ICC NETWORK ASSOCIATED WITH MICROBIOTA-MEDIATED GUT DYSFUNCTION | Emma Giordano |
| CDDW | Neurogastroenterology & Motility | A322 | ACTIVATION OF THE ARYL HYDROCARBON RECEPTOR DECREASES VISCERAL HYPERSENSITIVITY | Yasaman Habibyan |
| CDDW | Clinical Practice | A114 | OUT OF SCOPE: EVALUATING THE QUALITY, READABILITY, AND AGE-INCLUSIVITY OF ONLINE COLONOSCOPY EDUCATION FOR YOUNGER ADULTS | Adam Hassan |
| CDDW | Endoscopy, Technology & Imaging | A57 | ARTIFICIAL INTELLIGENCE–ASSISTED ENDOSCOPIC ASSESSMENT OF CROHN’S DISEASE SEVERITY: A SYSTEMATIC REVIEW | Elias Hazan |
| CDDW | Gastrointestinal Oncology | A164 | THE ASSOCIATION OF INFLAMMATORY BOWEL DISEASE WITH CARCINOID TUMORS: A CASE-BASED SYSTEMATIC REVIEW | Nathan He |
| CDDW | Clinical Practice | A135 | EFFECT OF MUSIC THERAPY ON PATIENT EXPERIENCE IN GASTROINTESTINAL ENDOSCOPY: A SCOPING REVIEW | Jason Hearn |
| CDDW | Pancreas | A318 | PANCREATIC ADENOCARCINOMA DIAGNOSED ON STANDARD ESOPHAGOGASTRODUODENOSCOPY | Jordana Herblum |
| CDDW | Cellular & Molecular Gastroenterology | A26 | FUNCTIONAL INTERACTION OF SIRT1 AND HNF4A IN INTESTINAL EPITHELIAL HOMEOSTASIS | Jehison Herrera Pulido |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A304 | VITAMIN D3 SUPPLEMENTATION AND ADHERENCE AMONG INFLAMMATORY BOWEL DISEASE PATIENTS | Samantha Hess |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A192 | REAL-WORLD OUTCOMES OF DUPILUMAB FOR TREATMENT OF EOSINOPHILIC ESOPHAGITIS | Thomas Hoang |
| CDDW | Endoscopy, Technology & Imaging | A74 | SAFETY AND EFFECTIVENESS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS USED TO PREVENT POST-ERCP PANCREATITIS IN HIGH-RISK POPULATIONS: AN OBSERVATIONAL COHORT STUDY | Megan Howarth |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A229 | USING SOCIETAL FACTORS TO PREDICT EPIDEMIOLOGIC STAGES OF INFLAMMATORY BOWEL DISEASE | Lindsay Hracs |
| CDDW | Endoscopy, Technology & Imaging | A63 | EUS-GUIDED CELIAC PLEXUS INTERVENTIONS IN PANCREATITIS AND PANCREATIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS | Malini Hu |
| CDDW | Cellular & Molecular Gastroenterology | A21 | DISRUPTION OF MUCIN-DERIVED SUGAR METABOLISM PATHWAYS IMPAIRS ENTERIC PATHOGEN CITROBACTER RODENTIUM COLONIZATION | Zhiquan Huang |
| CDDW | Endoscopy, Technology & Imaging | A53 | COMPUTER-AIDED COLONOSCOPY ALERT FATIGUE AND ITS EFFECT ON ADENOMA DETECTION | Felix Huang |
| CDDW | Liver | A184 | HEAT SHOCK PROTEIN 60 OVEREXPRESSION ATTENUATES HEPATIC INFLAMMATION AND FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS VIA REGULATION OF MITOCHONDRIAL STRESS–RELATED GENES | Ying-Hsien Huang |
| CLM | MASLD/MASH – Biomedical, Translational & Basic Science | P-110 | INTESTINAL PATHOBIONT AGGRAVATES LIVER INJURY IN A WESTERN DIET–INDUCED MODEL | Einav Hubelmanor |
| CDDW | Neurogastroenterology & Motility | A325 | THE NAUSEA ATLAS: IDENTIFYING AND CHARACTERIZING NAUSEA SUBTYPES USING PATIENT-REPORTED INFORMATION | Ken Hui |
| CDDW | Neurogastroenterology & Motility | A326 | CISPLATIN INDUCES A CONDITIONED TASTE REACTIVITY IN MICE THAT IS MITIGATED BY ONDANSETRON, ELABORATING ON A BEHAVIORAL MODEL TO STUDY CAUSES AND TREATMENTS OF NAUSEA | Ken Hui |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A253 | CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CHRONIC NONBACTERIAL OSTEOMYELITIS: A CASE SERIES | Mohammad Hussain |
| CDDW | Clinical Practice | A147 | ENDOSCOPIC FINDINGS IN NON-ANEMIC IRON DEFICIENCY | Louis Huynh |
| CDDW | Endoscopy, Technology & Imaging | A62 | INTESTINAL ULTRASOUND MEASUREMENT OF THE SUBMUCOSA BOWEL LAYER IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: THICKNESS CUT-OFFS FOR IDENTIFYING INFLAMED BOWEL | Hien Huynh |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A241 | DIETARY ARABINOXYLAN FIBER INTAKE ASSOCIATED WITH ANTIMICROBIAL HUMORAL RESPONSES AND DECREASED CROHN’S DISEASE RISK | Sean Jeong |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-59 | REAL-WORLD USE OF QUALITY INDICATORS & THEIR IMPACT ON OUTCOMES IN DECOMPENSATED CIRRHOSIS: A SCOPING REVIEW | Manisha Jogendran |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A288 | DIAGNOSTIC DILEMMA: INTESTINAL TUBERCULOSIS MIMICKING TERMINAL ILEAL CROHN’S DISEASE | Rohan Kakkar |
| CDDW | Endoscopy, Technology & Imaging | A72 | COMPARATIVE OUTCOMES OF ANESTHESIA VS. ENDOSCOPIST-CONTROLLED SEDATION IN ERCP: A RETROSPECTIVE STUDY | Rohan Kakkar |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A286 | DIFFERENCES IN ILEAL POUCH ANAL ANASTOMOSIS-RELATED FISTULAS VS. PERIANAL CROHN'S DISEASE | Rana Kandel |
| CDDW | Cellular & Molecular Gastroenterology | A35 | INVESTIGATING THE STING MEDIATED RESPONSE TO ENTERIC ADENOVIRUS INFECTION IN THE HUMAN INTESTINAL EPITHELIUM. | Essam Karam |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A261 | ASSESSING THE RELATIONSHIP BETWEEN FCP, CRP, AND THE HARVEY BRADSHAW INDEX IN PREGNANT PATIENTS WITH CROHN’S DISEASE | Kevin Kecskemeti |
| CDDW | Gastrointestinal Oncology | A162 | COLON-SPECIFIC MINIMALLY INVASIVE ENDOSCOPIC RESECTION OUTCOMES: A PROSPECTIVE MULTICENTER COHORT OF 1000 LARGE NON-PEDUNCULATED COLONIC POLYPS | Aslaan Karimuddin |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-32 | PATIENT REGIONAL DIFFERENCES AND CLINICAL OUTCOMES IN LIVER TRANSPLANT: A COHORT STUDY IN BRITISH COLUMBIA | Esther Kaye |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A201 | THE PREVALENCE OF EOSINOPHILIC ESOPHAGITIS AMONG PATIENTS WITH CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS | Kevin Kecskemeti |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A293 | ASSESSING ULCERATIVE COLITIS DISEASE ACTIVITY DURING PREGNANCY: A RETROSPECTIVE COHORT STUDY OF FECAL CALPROTECTIN, C-REACTIVE PROTEIN, AND THE PARTIAL MAYO SCORE. | Kevin Kecskemeti |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-133 | EXPLORING APOPTOSIS (M30) AND TOTAL CELL DEATH (M65) BIOMARKERS IN PEDIATRIC MASLD: INSIGHTS FROM A CANADIAN COHORT | Mohit Kehar |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A231 | ULTRASOUND ELASTOGRAPHY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF TECHNIQUES, PROTOCOLS, AND CLINICAL UTILITY TO DIFFERENTIATE FIBROSIS FROM INFLAMMATION | Roy Khalaf |
| CDDW | Pancreas | A317 | LONG-TERM OUTCOMES OF ENDOSCOPIC DRAINAGE MODALITIES IN PATIENTS WITH PANCREATIC AND PERIPANCREATIC FLUID COLLECTIONS FOLLOWING ACUTE PANCREATITIS: AN INTERNATIONAL MULTICENTER COHORT STUD | Kareem Khalaf |
| CDDW | Endoscopy, Technology & Imaging | A50 | IMPROVING OPTICAL DIAGNOSIS AND MANAGEMENT DECISION-MAKING SKILLS THROUGH COGNITIVE SIMULATION WITH DELIBERATE PRACTICE: A PROSPECTIVE COHORT STUDY | Rishad Khan |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-64 | IMPROVING RIFAXIMIN UTILIZATION WITH A BEST PRACTICE ADVISORY IN CONNECT CARE: INITIAL FINDINGS | Samina Khan |
| CDDW | Neurogastroenterology & Motility | A327 | PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY HAVE AN INCREASED PREVALENCE OF PATHOLOGIC REFLUX COMPARED TO SYMPTOMATIC PATIENTS WITH NORMAL ESOPHAGEAL MOTILITY | Ramey Kharfan |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A212 | DIETARY FATTY ACIDS ARE ASSOCIATED WITH ANTI-GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AUTOANTIBODIES IN FIRST-DEGREE RELATIVES OF CROHN’S DISEASE PATIENTS | Reihane Khorasaniha |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A279 | DISTINCT CLINICAL AND PATHOLOGIC CHARACTERISTCIS OF UC-ASSOCIATED NEOPLASIA AMONG PATIENTS UNDERGOING COLECTOMY: A 15-YEAR SINGLE-CENTRE COHORT STUDY | Jeongseok Kim |
| CDDW | Cellular & Molecular Gastroenterology | A29 | NUTRIENT-SENSING BY INTESTINAL TUFT CELLS: IMPLICATIONS FOR INFLAMMATORY BOWEL DISEASE | Abbey Kirkwood |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A249 | DETAILED COMPARISON OF MUCUS FUNCTION, HOST-MICROBE INTERACTIONS, AND COLITIS SUSCEPTIBILITY IN HUMANIZED MICE LACKING TERMINAL CORE STRUCTURES ON MUCINS | Darrek Kniffen |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A208 | PRIMARY HUMAN FECAL MUC2 ADMINISTRATION AMELIORATES COLITIS, DYSBIOSIS, AND MUCUS DEFECTS WITHIN A COLITOGENIC HUMANIZED INTESTINAL ECOSYSTEM IN MICE | Darrek Kniffen |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A259 | HUMAN INTESTINAL ORGANOID MODELLING OF CROHN'S DISEASE FISTULA FORMATION: PARTIAL EMT STATE DRIVES COLLECTIVE EPITHELIAL MIGRATION | Darasimi Kola-Ilesanmi |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A189 | FIRST PROSPECTIVE CANADIAN DATA OF THE WORLD-WIDE REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (WORLDHPREG) | Thomas Krahn |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A282 | CLINICAL OUTCOMES AND DRUG SUSTAINABILITY AFTER NON-MEDICAL SWITCH FROM USTEKINUMAB ORIGINATOR TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE | Justin Kritzinger |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A269 | INCIDENCE OF INFLAMMATORY ARTHRITIS BEFORE AND AFTER INFLAMMATORY BOWEL DISEASE DIAGNOSIS: A POPULATION-BASED COHORT STUDY | Ellen Kuenzig |
| CDDW | Gastrointestinal Oncology | A159 | IMPACT OF GLP-1 RECEPTOR AGONISTS ON BOWEL PREPARATION QUALITY IN PATIENTS UNDERGOING ELECTIVE COLONOSCOPY | Maxime Lamontagne |
| CDDW | Clinical Practice | A116 | IMPROVING PEDIATRIC CELIAC DISEASE EDUCATION: OVERCOMING CHALLENGES THROUGH DIGITAL INNOVATION IN A CANADIAN SETTING | Marihan Lansing |
| CDDW | Endoscopy, Technology & Imaging | A58 | EFFICACY AND SAFETY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL PHARYNGEAL CARCINOMAS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Gonzalo Latorre |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-67 | MTORC1 DRIVES EXAGGERATED M1-LIKE MACROPHAGE ACTIVATION IN ADVANCED LIVER FIBROSIS | David Lawton |
| CDDW | Clinical Practice | A112 | CYPROHEPTADINE USE IN CHILDREN 24 MONTHS AND YOUNGER: EFFICACY, SAFETY AND ROLE IN TUBE FEEDING WEANING | Bertrand Leduc |
| CDDW | Clinical Practice | A129 | FERTILITY CLINIC REFERRAL RATES IN AN IBD PREGNANCY AND PRECONCEPTION CLINICAL RESEARCH COHORT | Joy Lee |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-142 | LONGITUDINAL CHANGES IN BODY COMPOSITION IN PATIENTS WITH MODERATE-TO-ADVANCED MASH: A DESCRIPTIVE STUDY USING INBODY BIOIMPEDANCE ANALYSIS | Sangmin Lee |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-50 | TRENDS IN 1-YEAR POST-LIVER TRANSPLANT OVER TWO DECADES: A NATIONAL COHORT STUDY USING THE UNOS REGISTRY | Sangmin Lee |
| CDDW | Neurogastroenterology & Motility | A319 | UPREGULATION OF COLLAGEN 4 IS CORRELATED WITH INCREASED TISSUE STIFFNESS OF MOUSE EMBRYONIC MODEL OF HIRSCHSPRUNG DISEASE | Dorothy Lee |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-124 | MATERNAL OBESITY-INDUCED TRAINED IMMUNITY AND DEVELOPMENT OF STEATOTIC LIVER DISEASE IN OFFSPRING | Moonhyung Lee |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-88 | PRELIMINARY EVALUATION OF ANTI-HDV TESTING USING DRIED BLOOD SPOTS | EmmaR. Lee |
| CDDW | Cellular & Molecular Gastroenterology | A18 | EXPLORING THE REGULATORY ROLE OF ARID1A IN ADULT COLONIC HOMEOSTASIS AND INJURY RESPONSE | Diana (Qingran) Lei |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A295 | DEPLETION OF COLONIC HNF4A ACCENTUATES CITROBACTER RODENTIUM INFECTION SEVERITY IN FEMALE MICE | Linnette Leon Chirino |
| CDDW | Obesity, Metabolism & Nutrition | A89 | FOOD FOR MOOD: COMPARING THE EFFECTS OF THE MEDITERRANEAN DIET AND WESTERN DIET ON MENTAL HEALTH | Ayva Lewis |
| CDDW | Gastrointestinal Oncology | A156 | RECURRENCE RATES FOLLOWING ENDOSCOPIC MUCOSAL RESECTION (EMR) VERSUS ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR COLORECTAL POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS | Huaqi Li |
| CDDW | Gastrointestinal Oncology | A157 | EFFICACY OF ENDOSCOPIC MUCOSAL RESECTION (EMR) VERSUS ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR SUPERFICIAL DUODENAL LESIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Huaqi Li |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A237 | USE OF ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A RETROSPECTIVE STUDY | Huaqi Li |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A246 | SHOTGUN METAGENOMICS IDENTIFIES RUMINCOCCUS TORQUES AND ITS METABOLIC FUNCTION AS AN IMPORTANT CONTRIBUTOR TO CROHN’S DISEASE RISK | Qilong Li |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A313 | MATERNAL AND NEONATAL OUTCOMES OF RISANKIZUMAB IN PREGNANT PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE SERIES | Karen Li |
| CLM | MASLD/MASH – Biomedical, Translational & Basic Science | P-112 | METABOLIC DYSFUNCTION UNDERLIES GENERALIZED CD8 T CELL HYPERFUNCTION AND ASSOCIATES WITH POOR TUMOR RESPONSES IN MURINE LIVER DISEASE MODELS | Jeff Li |
| CDDW | Cellular & Molecular Gastroenterology | A44 | CHARACTERIZING THE NLRP6 INFLAMMASOME IN THE INTESTINAL EPITHELIUM | Lu Yi Li |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A205 | _x000D_
GASTRIC INLET PATCH PREVALENCE & ITS ASSOCIATION WITH GLOBUS SENSATION: ROLE OF INTENTIONAL ESOPHAGEAL INSPECTION | Catherine Liu |
| CDDW | Cellular & Molecular Gastroenterology | A36 | OPTIMIZING AND STANDARDIZING DONOR SCREENING FOR FECAL MICROBIOTA TRANSPLANTATION: A DELPHI REVIEW | Crystal Liu |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-49 | OUTCOME OF UTILIZING MELD 3.0 FROM A CANADIAN PERSPECTIVE | Crystal Liu |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-69 | A SINGLE-CELL ATLAS OF CHRONIC WOODCHUCK HEPATITIS-INDUCED HEPATOCELLULAR CARCINOMA (HCC) REVEALS CONSERVED TUMOR-DRIVEN IMMUNE EXHAUSTION IN HUMAN HCC | Yijia Liu |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A315 | IMPLEMENTATION OF ACCEPTANCE AND COMMITMENT THERAPY IN INFLAMMATORY BOWEL DISEASE: A SCOPING REVIEW | Clara Long |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A302 | PREVALENCE AND EPIDEMIOLOGICAL FEATURES OF ADULT UPPER GASTROINTESTINAL CROHN'S DISEASE OVER THE LAST 30 YEARS: A SCOPING REVIEW | Daniel Lupas |
| CDDW | Clinical Practice | A139 | EXPLORING THE ROLE OF COMMUNITY SUPPORTS IN IMPROVING OUTCOMES FOR RECENTLY DISCHARGED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW | Maria MacDonald |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A216 | OVER 25% OF INFLAMMATORY BOWEL DISEASE ADVANCED THERAPY DOSE ESCALATIONS ARE BASED ON SYMPTOMS ALONE: A QUALITY IMPROVEMENT OPPORTUNITY | Scott MacKay |
| CLM | Other liver disease - Biomedical, Translational & Basic Science | P-020 | INVERSION OF THE AST/ALT RATIO IN CIRRHOSIS: EXPLORATORY MECHANISTIC OBSERVATIONS. | Karine Lyonnais |
| CLM | Other liver disease - Biomedical, Translational & Basic Science | P-021 | NOVEL IN VITRO MODEL OF HEPATIC STEATOSIS INDUCED BY EXPOSURE TO HUMAN CIRRHOTIC LIVER HOMOGENATES | Karine Lyonnais |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-65 | DISTINCT EXHAUSTION AND MEMORY SIGNATURES OF HCV-SPECIFIC CD8⁺ T CELLS ACROSS INFECTION OUTCOMES AND EARLY TREATMENT | Ayoub Mahassine |
| CDDW | Endoscopy, Technology & Imaging | A67 | ENDOSCOPIC POLYP SIZE MEASUREMENT USING A LASER-BASED SIZING PROBE: A PILOT STUDY | Mohamed Zineddine Mahdadi |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-143 | RISK STRATIFICATION BY LONGITUDINAL FIB-4 BIOMARKER MEASUREMENTS IN PATIENTS WITH MASLD/MASH | Suraj Mahida |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A223 | STUDIES BASED ON HEALTH ADMINISTRATIVE DATA REGARDING RARE OUTCOMES IN INFLAMMATORY BOWEL DISEASE SIGNIFICANTLY UNDERESTIMATE THE TRUE RISK - THE IMPORTANCE OF SPECIFICITY | Mikkel Malham |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-98 | THE INCIDENCE, PREVALENCE, MEDICATION EXPOSURE, AND TRANSPLANTATION RATES IN PAEDIATRIC AUTOIMMUNE HEPATITIS – A NATIONWIDE DANISH COHORT STUDY | Mikkel Malham |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-56 | EOSINOPHILIC CHOLANGITIS: A COMPREHENSIVE SYSTEMATIC REVIEW OF A RARE INFLAMMATORY BILIARY DISORDER | Gurjit Mander |
| CDDW | Obesity, Metabolism & Nutrition | A88 | MULTI-OMIC FECAL BIOMARKERS PREDICT PERSISTENT METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE AFTER BARIATRIC SURGERY IN PATIENTS WITH MORBID OBESITY: A PRECISION MEDICINE APPROACH | Paraskevi Massara |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-31 | CREATION OF EDUCATIONAL RESOURCES FOR REGISTERED NURSES TO LEARN PARACENTESIS. | Molly McDonald |
| CDDW | Clinical Practice | A119 | ONE VERSUS TWO FECAL IMMUNOCHEMICAL TESTS IN THE DETECTION OF ADVANCED COLORECTAL NEOPLASIA | Brayden McGrath |
| CDDW | Cellular & Molecular Gastroenterology | A39 | CHARACTERIZING THE ROLE OF STING IN THE INTESTINAL EPITHELIUM | Justin Meade |
| CDDW | Endoscopy, Technology & Imaging | A61 | CLINICAL & PROCEDURAL PREDICTORS OF ERCP TECHNICAL SUCCESS & ADVERSE EVENTS IN PATIENTS AGED < 60 VS ≥ 60 YEARS: A RETROSPECTIVE COHORT STUDY | Vrati Mehra |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-81 | DOES HEPATITIS C RUN IN THE FAMILY? UNCOVERING SIBLING TIES TO VERTICAL TRANSMISSION USING HEALTH ADMINISTRATIVE DATA | Andrew Mendlowitz |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-132 | COMPARISON OF MAGNETIC RESONANCE ELASTOGRAPHY WITH VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY AND FIB-4 FOR MASLD FIBROSIS SEVERITY | Maria MIKAIL |
| CDDW | Endoscopy, Technology & Imaging | A75 | TOTAL EXAMINATION TIME IN UPPER GASTROINTESTINAL ENDOSCOPY AND LESION DETECTION: A PROSPECTIVE STUDY | Sacha Mitchell |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A210 | PREDICTIVE VALUE OF INTESTINAL ULTRASOUND FOR TREATMENT RESPONSE AND LONG-TERM OUTCOMES IN SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW | Moneer Mohammed |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-63 | ASSESSING THE EFFICACY AND OUTCOMES OF PERCUTANEOUS CHOLECYSTOSTOMY IN HIGH-RISK SURGICAL PATIENTS WITH ACUTE CHOLECYSTITIS: A RETROSPECTIVE STUDY AT KINGSTON HEALTH SCIENCE CENTRE | Rana Mohanna |
| CDDW | Cellular & Molecular Gastroenterology | A25 | INFECTION WITH THE CROHN’S DISEASE PATHOBIONT E. COLI-LF82 REVEALS MITOCHONDRIAL DNA RELEASE AND CGAS-STING ACTIVATION | Armaan Mohan |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A287 | REAL-WORLD OUTCOMES OF MIRIKIZUMAB THERAPY FOR ULCERATIVE COLITIS | Jonah Moore |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-87 | GENETIC PREDISPOSITION TO PORTAL THROMBOSIS: A CASE REPORT OF FACTOR V AND FACTOR XIII MUTATIONS | MariaVictoria MoralesHernandez |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-027 | THE IMPACT OF ACUTE RENAL FAILURE ON THE PROGNOSIS OF PATIENTS WITH DECOMPENSATED CIRRHOSIS AND ACUTE ON CHRONIC LIVER FAILURE | Aoife Moriarty |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-101 | BRIDGE PROJECT: OVERVIEW AND FINDINGS ON MEANINGFUL ENGAGEMENT WITH IMMIGRANT COMMUNITIES ON HEPATITIS B | Richard Morrow |
| CDDW | Clinical Practice | A145 | RETROSPECTIVE SINGLE CENTER REVIEW OF ENDOSCOPIC PROCEDURES REQUIRING ANESTHEISA ASSISTANCE IN THE OPERATING ROOM | Kasey Moss |
| CDDW | Cellular & Molecular Gastroenterology | A24 | PARIETAL CELLS AS PRIMARY TARGETS OF VACA: SINGLE-CELL INSIGHTS INTO GASTRIC REMODELING | Emanuel Muruaga |
| CLM | Autoimmune Liver Disease – Biomedical, Translational & Basic Science | P-6 | MULTI-OMIC CELLULAR ECOSYSTEM PROFILING IDENTIFIES THAT PSC PROGRESSION IS CHARACTERIZED BY STEPWISE IMMUNE RECRUITMENT AND PROGRESSIVE IMMUNE EXHAUSTION | Diana Nakib |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-134 | PROVIDER PERSPECTIVES AND PRACTICES IN THE DIAGNOSIS AND MANAGEMENT OF MASLD IN BRITISH COLUMBIA: A MULTI-CENTER SURVEY | Estello NapHill |
| CLM | Other liver disease - Biomedical, Translational & Basic Science | P-017 | UREA CYCLE FUNCTION AND AMMONIA METABOLISM IN HEPATOCELLULAR CARCINOMA | Gaia Nassar |
| CDDW | Gastrointestinal Oncology | A168 | PATIENT-DERIVED ORGANOIDS TO ACCELERATE COLORECTAL CANCER RESEARCH | Sonya Nassari |
| CDDW | Obesity, Metabolism & Nutrition | A91 | SECONDARY BILE ACIDS MEDIATE METABOLIC RECOVERY POST-BARIATRIC SURGERY | Nayanan Nathan |
| CDDW | Endoscopy, Technology & Imaging | A77 | THE DUAL-CHANNEL CLIP-AND-SNARE TRACTION TECHNIQUE: A NOVEL APPROACH TO BILIARY CANNULATION DURING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN A PATIENT WITH ROUX-EN-Y ANATOMY | Nabil Nathoo-Khedri |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A213 | PREDICTING SUSTAINED REMISSION AND MAXIMAL DISEASE SEVERITY IN PEDIATRIC CROHN’S DISEASE USING MACHINE LEARNING | Irvin Ng |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A291 | THE ENVIRONMENTAL IMPACT OF VIRTUAL SPECIALIST CARE AMONG INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE IN ONTARIO | Luke Nguyen |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A292 | COMPARATIVE EFFICACY AND SAFETY OF IL-23P19 INHIBITORS IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROL TRIALS | Bachviet Nguyen |
| CLM | ALD - Clinical Science, Epidemiology & Public Health | P-001 | RISK FACTORS AND OUTCOMES OF ACUTE KIDNEY INJURY IN ALCOHOLIC HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Bachviet Nguyen |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-8 | COMPARATIVE OUTCOMES OF PRIMARY SCLEROSING CHOLANGITIS WITH AND WITHOUT COMORBID INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS | Bachviet Nguyen |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-82 | BRIDGING GAPS FOR VULNERABLE POPULATIONS: ADVOCATING FOR EQUITABLE ACCESS TO HEPATITIS B TREATMENT ACROSS CANADA | AnhThu Nguyen-Lefebvre |
| CDDW | Intestinal Disorder | A85 | SOCIAL DETERMINANTS OF HEALTH AND HEALTH OUTCOMES IN CELIAC DISEASE: A SCOPING REVIEW | Catherine Nie |
| CDDW | Clinical Practice | A136 | BEYOND H. PYLORI: A RARE CASE OF REFRACTORY HELICOBACTER HEILMANNII GASTRITIS LINKED TO IRON DEFICIENCY ANEMIA | Seyedeh Niki |
| CDDW | Cellular & Molecular Gastroenterology | A45 | HOST RESPONSE TO BACTERIA INDUCES A SHIFT TOWARDS THE ENTEROENDOCRINE CELL LINEAGE IN MURINE ENTEROIDS | Marry Nissan |
| CDDW | Clinical Practice | A97 | BARRIERS AND FACILITATORS TO GLUTEN-FREE DIET ADHERENCE IN ADULTS WITH CELIAC DISEASE: A QUALITATIVE STUDY | Vanina Noejovich |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A243 | COMORBIDITY BURDEN AND MORTALITY IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE | Shinji Okabayashi |
| CDDW | Endoscopy, Technology & Imaging | A47 | COMPUTER-ASSISTED VERSUS UNASSISTED OPTICAL DIAGNOSIS OF COLORECTAL POLYPS: RESULTS FROM A LARGE PRAGMATIC IMPLEMENTATION STUDY | Megan Oleksiw |
| CDDW | Endoscopy, Technology & Imaging | A66 | UPSKILLING OF OPTICAL DIAGNOSIS PERFORMANCE OVER TIME WITH COMPUTER ASSISTED DIAGNOSIS USE: RESULTS FROM A LARGE PROSPECTIVE COHORT | Megan Oleksiw |
| CDDW | Cellular & Molecular Gastroenterology | A40 | SHORT-CHAIN FATTY ACIDS AS POTENTIAL MODULATORS OF TYPE III INTERFERON SIGNALING THROUGH EPIGENETIC REGULATION | Testimony Olumade |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-015 | OVERLAPPING SYNDROME OCCURRING IN THE LATE POSTPARTUM PERIOD | Rafael OrellanaArriaga |
| CDDW | Clinical Practice | A99 | _x000D_
REMIFENTANIL'S EFFECT ON PROPOFOL SEDATION IN MARIJUANA USERS UNDERGOING ESOPHAGODUODENOSCOPY | Sophia Ostrovski |
| CDDW | Clinical Practice | A141 | IMPACT OF REFERRAL PATHWAY ON COLONOSCOPY OUTCOMES IN ADULTS AGED 75 YEARS AND OLDER | Vishesh Patel |
| CDDW | Cellular & Molecular Gastroenterology | A41 | TESTING THE EFFECTS OF TIME RESTRICTED FEEDING IN COLORECTAL TUMORIGENESIS | Rachna Patel |
| CDDW | Cellular & Molecular Gastroenterology | A30 | INVESTIGATING THE IMPACT OF PARKINSON’S DISEASE-ASSOCIATED GENE PINK1 ON INTESTINAL HOMEOSTASIS AND RESPONSE TO INFECTION | Jessica Pei |
| CDDW | Cellular & Molecular Gastroenterology | A27 | COLLAGEN-PRODUCING, GFP-TAGGED BONE-MARROW DERIVED CELLS MIGRATE TO COLONIC LAMINA PROPRIA AND MAY CONTRIBUTE TO INTESTINAL FIBROSIS IN A MURINE MODEL OF COLITIS | Richard Peng |
| CDDW | Clinical Practice | A115 | GAMING IN GASTROENTEROLOGY: A RANDOMIZED CONTROLLED TRIAL | Janaya Perron |
| CDDW | Endoscopy, Technology & Imaging | A49 | DIRECT TRANSNASAL PLACEMENT OF ENDOLUMINAL VACUUM THERAPY UNDER CONSCIOUS SEDATION: A SINGLE-CENTER CASE SERIES | Neel Phaterpekar |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-76 | SINGLE-MOLECULE IMAGING REVEALS HEPATITIS C VIRUS REPLICATION ORGANELLES CONTAIN A SINGLE-COPY OF THE NEGATIVE-STRAND REPLICATIVE INTERMEDIATE. | Nathan Pilkey |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-48 | PRE-OPERATIVE ANTIBIOTIC USE AND RATE OF COMPLICATION FOR MICROWAVE AND RADIOFREQUENCY ABLATION - A RETROSPECTIVE ANALYSIS | Shaylin Pillay |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-96 | CASE REPORT: SYSTEMIC HSV HEPATITIS IN PREGNANCY | Krystyna Pokraka |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A193 | DUPILUMAB IMPROVES FEATURES OF EOSINOPHILIC ESOPHAGITIS REGARDLESS OF ENDOSCOPIC PHENOTYPE: LIBERTY EOE TREET STUDY POST HOC ANALYSIS | Remy Pollock |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-89 | TELEMEDICINE AND HYBRID ENGAGEMENT MODELS FACILITATE HEPATITIS C CASCADE OF CARE DURING PERIODS OF HEALTHCARE DISRUPTION | Haris Imsirovic |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A196 | DUPILUMAB IMPROVES DYSPHAGIA, ODYNOPHAGIA, CHEST PAIN, AND HEARTBURN IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS UP TO 52 WEEKS: POST HOC ANALYSIS OF THE LIBERTY EOE TREET STUDY | Remy Pollock |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A187 | FOOD-SPECIFIC CD4+ FOXP3+ REGULATORY T CELLS IDENTIFY DELAYED-HYPERSENSITIVITY ALLERGIES AND FOOD TRIGGERS IN PEDIATRIC PATIENTS | Chad Poloni |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A262 | TREATMENT OF CROHN’S DISEASE-ASSOCIATED GASTRIC OUTLET OBSTRUCTION: A SCOPING REVIEW | Amarpreet Powar |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-014 | TUMOUR SEEDING WITH PERCUTANEOUS RADIOFREQUENCY ABLATION OF PRIMARY HEPATOCELLULAR CARCINOMA - A SYSTEMATIC REVIEW | Riya Prajapati |
| CDDW | Neurogastroenterology & Motility | A323 | BACTERIA-DERIVED SATURATED AND MONOUNSATURATED LYSOPHOSPHOLIPIDS CONTRIBUTE TO VISCERAL PAIN IN PATIENTS WITH IBS | Mohammad Ismail Quaderi |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A281 | MIXED-METHOD QUANTITATIVE SURVEY AND QUALITATIVE PATIENT-LED FOCUS GROUP STUDY EXPLORING PATIENT PERSPECTIVES ON DIGITAL TOOLS FOR INFLAMMATORY BOWEL DISEASE SELF-CARE | Sophia Quan |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-129 | DISTRIBUTION OF LIVER FIBROSIS/ STEATOSIS ACROSS AGE AND SEX IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASE OF VARIOUS AETIOLOGIES FOLLOWED AT TORONTO LIVER CENTRE: IMPACT OF UTILIZATION OF FIBROSCAN®. | Jumshaid Qureshi |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-90 | TIME TO HEPATITIS C CARE ENGAGEMENT AND TREATMENT OUTCOMES IN CANADIAN IMMIGRANTS HAVE MARKEDLY IMPROVED OVER THREE DECADES | Haris Imsirovic |
| CDDW | Endoscopy, Technology & Imaging | A51 | COGNITIVE LOAD AND ADENOMA DETECTION IN IBD SURVEILLANCE COLONOSCOPY: A PROSPECTIVE STUDY | Chelssy Ingabire |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-130 | HIGHER PREVALENCE OF METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) WITH ADVANCED LIVER FIBROSIS / CIRRHOSIS IN A COHORT OF PATIENTS FOLLOWED AT TORONTO LIVER CENTRE: IMPACT OF UTILIZATION OF LIVER ELASTOGRAPHY AND SPLEEN STIFFNESS. | Jumshaid Qureshi |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-38 | SPLEEN STIFFNESS MEASUREMENT IS BENEFICIAL IN PATIENTS WITH NORMAL OR SLIGHTLY INCREASED LIVER STIFFNESS AND CLINICAL OR LABORATORY SUSPICION OF THE PRESENCE OF PORTAL HYPERTENSION; AN EXPERIENCE OF AN URBAN LIVER CENTRE IN TORONTO (TLC) | Jumshaid Qureshi |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-39 | SPLEEN STIFFNESS MEASUREMENT REFINES THE ASSESSMENT OF PORTAL HYPERTENSION AND MAY PREDICT DECOMPENSATION IN A COHORT OF PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS FOLLOWED AT AN URBAN LIVER CENTRE IN TORONTO (TLC). | Jumshaid Qureshi |
| CDDW | Clinical Practice | A153 | PRELIMINARY RESULTS ON THE EFFECTIVENESS OF A MENTAL HEALTH PATHWAY FOR IBD | Ella Rahime |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A284 | IMPROVEMENT OF BOWEL URGENCY WITH ADVANCED INFLAMMATORY BOWEL DISEASE THERAPIES: A SYSTEMATIC REVIEW AND META-ANALYSIS. | Nitin Rai |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-115 | INCOME AND SEX DIFFERENCES ARE DRIVING FACTORS IN DISEASE PROGNOSIS: A SURVIVAL ANALYSIS OF A COHORT OF INDIVIDUALS WITH MASLD IN THE CANADIAN LONGITUDINAL STUDY OF AGING | Carmela Rapino |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-116 | EVALUATION OF THE PROGNOSTIC UTILITY OF STEATOTIC LIVER DISEASE SUBCLASSES IN ASSOCIATION WITH ALL-CAUSE MORTALITY: A TIME-VARYING SURVIVAL ANALYSIS OF THE CANADIAN LONGITUDINAL STUDY ON AGING | Carmela Rapino |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-73 | REAL-TIME INTRAVITAL MICROSCOPY APPROACH FOR CHARACTERIZING HCC MICROENVIRONMENT IN THE WOODCHUCK MODEL OF HEPATITIS B. | MdDeen Islam |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-68 | MECHANISMS OF HEPATITIS VIRUS DISSEMINATION IN LIVER: DO KUPFFER CELLS FACILITATE TRANSFER FROM BLOOD TO HEPATOCYTES? | MdMahamudUr Rashid |
| CDDW | Clinical Practice | A137 | FROM REFERRAL TO RELIEF: IMPROVING WAIT TIMES FOR URGENT GASTROENTEROLOGY CONSULTATION IN CALGARY | Christina Ray |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A299 | LONG TERM OUTCOMES IN SMALL BOWEL CROHN’S DISEASE STRICTURES WITH PRE-STENOTIC DILATION ON INTESTINAL ULTRASOUND | Rohita Reji |
| CDDW | Intestinal Disorder | A83 | SUPPORTING TRANSITION IN CELIAC DISEASE: USABILITY TESTING OF A YOUTH-FOCUSED TRANSITION GUIDEBOOK | Ella Rival |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-118 | DIAGNOSTIC ACCURACY OF NON-INVASIVE TESTS FOR MODERATE FIBROSIS (F2-3) IN MASLD: A REAL-WORLD CANADIAN COHORT | Angelica Rivas |
| CDDW | Clinical Practice | A124 | PERCUTANEOUS TRANSHEPATIC BILIARY DRAINAGE (PTBD) FOR MALIGNANT HILAR BILIARY OBSTRUCTION (MHBO) IS ASSOCIATED WITH POOR OUTCOMES – IS IT TIME TO REASSESS ITS CLINICAL UTILITY? | Alexandra Robertson |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-144 | SEMAGLUTIDE COMBINED WITH INDIVIDUAL NUTRITIONAL INTERVENTION FOR THE TREATMENT OF MASLD/MASH | Tristan Rocheleau |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A242 | WHAT IS THE CURRENT LANDSCAPE OF IBD NURSING IN CANADA AND ARE THERE ENOUGH NURSES TO HELP CARE FOR PERSONS WITH IBD? | Noelle Rohatinsky |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A234 | DIETARY ENHANCEMENT OF MICROBIAL TRYPTOPHAN METABOLISM RESTORES AHR SIGNALLING AND REDUCES COLITIS | Liam Rondeau |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A225 | REAL-WORLD DATA ON THE EFFECTIVENESS OF INTRAVENOUS RISANKIZUMAB RESCUE IN CROHN’S DISEASE | Ryan Rosentreter |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-016 | EXAMINING THE IMPACT OF INFLAMMATORY BOWEL DISEASE REGARDING POST-TRANSPLANT OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS | Yashasavi Sachar |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-107 | ENHANCING EPIDEMIOLOGICAL MODELLING THROUGH STAKEHOLDER ENGAGEMENT: A FOCUS GROUP STUDY ON HEPATITIS C PREVALENCE IN CANADA | Yasmin Saeed |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A306 | USING CLINICAL FACTORS TO PREDICT TREATMENT OUTCOMES AND HEALTH-CARE UTILIZATION IN PATIENTS WITH CROHN’S DISEASE INITIATING ADVANCED THERAPIES | Hussain Safar |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-75 | MIR-122 MEDIATES THE SWITCH FROM TRANSLATION TO REPLICATION IN THE HEPATITIS C VIRUS LIFE CYCLE. | Michelle Sag |
| CDDW | Clinical Practice | A134 | EVALUATING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PANCREATITIS PREVENTION MEASURES AMONGST TWO TERTIARY CARE CENTERS IN WINNIPEG, MANITOBA: A QUALITY IMPROVEMENT STUDY | Gagan Deep Sambhi |
| CDDW | Endoscopy, Technology & Imaging | A73 | OVERCOMING PHYSICAL BARRIERS TO ENDOSCOPY WITH AN ADAPTIVE SUPPORT DEVICE FOLLOWING A LEFT UPPER EXTREMITY INJURY | Gagan Deep Sambhi |
| CDDW | Clinical Practice | A144 | PATIENT AND HEALTHCARE PROVIDER VOICES – LISTENING TO IMPROVE: EVALUATING A MULTIDISCIPLINARY COORDINATION OF CARE PATHWAY FOR PANCREATICOBILIARY CANCER | Gurpal Sandha |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A219 | CHARACTERIZATION OF METHYLATION MODIFICATIONS OF HUMAN COLONOID MONOLAYERS ESTABLISHED AS IN VITRO CHRONIC DAMAGE MODEL | Shruti Sandilya |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A308 | BEYOND THE USUAL SUSPECT: RARE COEXISTENCE OF CROHN'S DISEASE AND COLLAGENOUS COLITIS | Alexa Sasson |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A233 | INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH AN INCREASED RISK OF END-STAGE RENAL DISEASE: A POPULATION-BASED COHORT STUDY | Onuma Sattayalertyanyong |
| CDDW | Gastrointestinal Oncology | A176 | MANTLE CELL LYMPHOMA DIAGNOSED ON FIT-POSITIVE COLONOSCOPY: A CASE REPORT AND REVIEW OF GASTROINTESTINAL LYMPHOMA | Matthew Saunders |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A257 | THE IMPACT OF FISTULAS IN PATIENTS WITH ILEAL POUCH ANAL ANASTOMOSIS: A COMPARATIVE COHORT STUDY | Nawid Sayed |
| CDDW | Gastrointestinal Oncology | A173 | EN-BLOC RESECTION RATE USING ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) IN THE MANAGEMENT OF RECTAL POLYPS: A RETROSPECTIVE COHORT STUDY | Michael Scaffidi |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-128 | INCIDENCE AND IMPACT OF HEPATIC STEATOSIS IN PEOPLE WITH HIV: INSIGHTS FROM THE NORTH AMERICAN AIDS COHORT COLLABORATION ON RESEARCH AND DESIGN (NA-ACCORD) | Giada Sebastiani |
| CLM | Other liver disease - Biomedical, Translational & Basic Science | P-022 | MACROPHAGE COLONY STIMULATING FACTOR PROLONGS KUPFFER CELL SURVIVAL PHENOTYPE AND PHAGOCYTIC POTENTIAL FUNCTION IN VITRO | Manmeet Sekhon |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A238 | PERFORMANCE OF FECAL CALPROTECTIN AS A SURROGATE MARKER FOR EXTENT OF DISEASE IN CROHN’S DISEASE AND ULCERATIVE COLITIS AT DIAGNOSIS | Jonathan Sgro |
| CDDW | Clinical Practice | A123 | OBSTETRICS AND GYNECOLOGY HEALTHCARE UTILIZATION IN PERONS WITH IBS AND IBD | Pratik Shah |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A247 | DIETARY TRACKING REVEALS PERSONALIZED DIET RESPONSES LINKED TO GUT INFLAMMATION AND MICROBIOME VARIATION IN CROHN’S DISEASE FIRST-DEGREE RELATIVES | Ishfaq Shah |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-85 | GEOGRAPHIC VARIATION OF HEPATITIS D VIRUS TESTING AMONG PATIENTS WITH CHRONIC HEPATITIS B IN CANADA: A POPULATION-BASED STUDY. | Abdel-Aziz Shaheen |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A245 | URINARY METABOLITES IDENTIFY FIRST-DEGREE RELATIVES AT RISK OF DEVELOPING CROHN’S DISEASE | Tali Sharar Fischler |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-137 | DIAGNOSTIC YIELD AND EFFICIENCY OF NON-INVASIVE TWO-TIER PATHWAYS FOR LIVER FIBROSIS ASSESSMENT IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE | Neha Sharma |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A240 | IMMIGRANT STATUS AND WORK PRODUCTIVITY LOSS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT STUDY | Dropen Sheka |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A311 | EVALUATION OF BARRIERS TO OUTPATIENT ADVANCED THERAPY INITIATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | Paige Shelemey |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A228 | NEO-TERMINAL ILEUM HISTOLOGY PREDICTS LONG-TERM CLINICAL OUTCOMES IN POSTOPERATIVE CROHN'S DISEASE PATIENTS IN ENDOSCOPIC REMISSION | Steven Shen |
| CDDW | Cellular & Molecular Gastroenterology | A34 | IMAGING MASS CYTOMETRY REVEALS ALTERED IMMUNE CELL SPATIAL RELATIONSHIPS DURING INFLAMMATORY BOWEL DISEASE EXACERBATIONS | Olimpia Sienkiewicz |
| CDDW | Endoscopy, Technology & Imaging | A60 | A SURVEY EVALUATING USER PERCEPTIONS OF A COMMERCIAL ARTIFICIAL INTELLIGENCE-BASED POLYP DETECTION SYSTEM DURING COLONOSCOPY | Japjyot Singh |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A285 | RISK OF COLECTOMY AFTER APPENDECTOMY IN ESTABLISHED ULCERATIVE COLITIS: A SYSTEMIC REVIEW AND META-ANALYSIS | Sahra Siyad |
| CDDW | Endoscopy, Technology & Imaging | A56 | DOUBLE-BALLOON-ERCP IN POST-LIVER TRANSPLANT PATIENTS WITH ROUX EN Y HEPATICOJEJUNOSTOMY: ANALYSIS OF OUTCOMES IN A SINGLE CANADIAN CENTRE | John Soleas |
| CDDW | Endoscopy, Technology & Imaging | A46 | IMPROVING INTER-OBSERVER AGREEMENT IN ENDOSCOPIC FINDINGS WITH STNDARDIZED TERMINOLOGY | Yi Nong Song |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-54 | USING NON-INVASIVE LIVER FIBROSIS INDICES TO PREDICT VARICEAL BLEEDING IN CIRRHOTIC PATIENTS PRESENTING WITH UPPER GASTROINTESTINAL BLEEDING: A RETROSPECTIVE COHORT STUDY | YiNong Song |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A270 | INVESTIGATING USP18 DEFICIENCY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE | Sabrina Sorbara |
| CDDW | Cellular & Molecular Gastroenterology | A23 | FASTING REMODELS THE COLONIC MICROBIOTA AND INCREASES GOBLET CELL AUTOPHAGY TO PRESERVE THE MUCUS BARRIER | Shokufeh Sorboni |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A226 | SYSTEMIC INFLAMMATORY PATHWAYS LINK LOW BRAIN CORTICAL OXYGENATION TO SYMPTOM SEVERITY IN CROHN’S DISEASE | Ateyeh Soroush |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A239 | YOU ARE WHAT EATS YOU: EXPLORING MUCIN DEGRADATION BY THE IBD PATHOBIONT CANDIDA ALBICANS | James Sousa |
| CDDW | Clinical Practice | A98 | SOCIOECONOMIC FACTORS, ETHNICITY, AND EDUCATION IMPACT QUALITY OF LIFE AND MENTAL HEALTH IN PREGNANT IBD PATIENTS | Varun Srikanth |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A194 | EPIDEMIOLOGY OF ANTI-REFLUX MEDICATION USE IN VERY PRETERM INFANTS | Hannah Stevens |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A255 | DISCORDANCE BETWEEN BMI AND VISCERAL ADIPOSITY IDENTIFIES DISTINCT INFLAMMATORY PHENOTYPES IN INFLAMMATORY BOWEL DISEASES | Joelle St-Pierre |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A278 | HIGHER BMI DOES NOT IMPAIR VISUALIZATION OF BOWEL SEGMENTS OR ANASTOMOSES IN INTESTINAL ULTRASOUND | Joelle St-Pierre |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A314 | LOWER VISCERAL FAT ASSOCIATES WITH ACTIVE DISEASE IN MEN BUT NOT WOMEN WITH INFLAMMATORY BOWEL DISEASES | Joelle St-Pierre |
| CDDW | Cellular & Molecular Gastroenterology | A22 | INVESTIGATING THE ROLE OF YAP/TAZ IN GASTRIC METAPLASIA AND CANCER DEVELOPMENT | Jacqueline Sung |
| CLM | ALD - Clinical Science, Epidemiology & Public Health | P-002 | SOCIODEMOGRAPHIC DRIVERS LINKING ALCOHOL SALES AND NEW HOSPITALIZATIONS FOR ALCOHOL-RELATED CIRRHOSIS IN ALBERTA, CANADA. | Liam Swain |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-102 | LONGITUDINAL PATTERNS OF QUANTITATIVE HBSAG DECLINE IN A LARGE REAL-WORLD COHORT OF CHRONIC HEPATITIS B PATIENTS | Sanam TabatabaVakili |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-35 | LIVER HEALTH CONNECT: A COMMUNITY-FIRST APPROACH TO ADVANCING LIVER HEALTH AWARENESS AND ENGAGEMENT | George Tadros |
| CDDW | Gastrointestinal Oncology | A166 | STOOL HEMOGLOBIN OF OLDER PATIENT POLYP SURVEILLANCE (SHOPPS): FEASIBILITY OF FIT COLLECTION AND INTERIM PROGRESS REPORT | Cheng-Chun Tai |
| CDDW | Clinical Practice | A131 | HYDROXYUREA-INDUCED ILEOCOLONIC ULCERATION: A CROHN'S DISEASE MIMICKER | Benson Tam |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-012 | CLINICAL CHARACTERISTICS AND BIOCHEMICAL PREDICTORS OF RECURRENT PRIMARY SCLEROSING CHOLANGITIS POST LIVER TRANSPLANTATION | Natassia Tan |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-74 | CHARACTERIZING THE IMMUNE LANDSCAPE OF INDIVIDUALS WITH CHRONIC HEPATITIS B AFTER HBV SURFACE ANTIGEN (HBSAG) LOSS | Michelle Tang |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A198 | TEMPORAL TRENDS IN ANTI-REFLUX MEDICATION USE IN VERY PRETERM INFANTS: A POPULATION-BASED COHORT STUDY | Sophie Tanner |
| CLM | MASLD/MASH – Biomedical, Translational & Basic Science | P-109 | VISCERAL ADIPOCYTE HYPERTROPHY IS A MARKER OF METABOLIC DYSFUNCTION AND THE PRESENCE OF BIOPSY-PROVEN LIVER STEATOSIS IN MEN AND WOMEN WITH SEVERE OBESITY | Andre Tchernof |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A275 | PREDICTING RISK FOR VENOUS THROMBOEMBOLISM AFTER HOSPITAL DISCHARGE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | Gimantha Tennakoon |
| CDDW | Clinical Practice | A94 | AUTOMATING POST-ENDOSCOPY FOLLOW-UP VIA SHORT MESSAGE SERVICE (SMS): EFFECTIVENESS AND FEASIBILITY | Micah Ten-Pow |
| CDDW | Cellular & Molecular Gastroenterology | A20 | _x000D_
ODIN: AN UNBIASED BRIGHTFIELD IMAGE-BASED MACHINE LEARNING ALGORITHM FOR INTESTINAL ORGANOID CHARACTERIZATION | Holden Teslak |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A256 | IL1B-RS1143634 ASSOCIATED TO NONRESPONSE TO INFLIXIMAB IN ULCERATIVE COLITIS TREATMENT | Laurence Tessier |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A207 | EXPANSION OF PERIPHERAL RORγT+ POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS (PMN-MDSCS) SIGNALS EARLY IMMUNE DYSREGULATION LINKED TO CROHN’S DISEASE RISK | Bhupesh Kumar Thakur |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-010 | NATURAL HISTORY OF PRIMARY BILIARY CHOLANGITIS: ANALYSIS OF DEMOGRAPHICS, THERAPY, AND BIOCHEMICAL RESPONSE FROM THE ALBERTA PBC REGISTRY. | Bryce Tkachuk |
| CLM | Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health | P-9 | PROVINCIAL TRENDS IN PRIMARY BILIARY CHOLANGITIS (PBC) INCIDENCE AND PREVALENCE IN ALBERTA, 2002–2021: ASSESSMENT OF ZONAL VARIATIONS | Bryce Tkachuk |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-148 | GREATER IMPROVEMENTS IN BILIRUBIN WERE OBSERVED IN PRURITUS RESPONDERS AFTER MARALIXIBAT TREATMENT IN PATIENTS WITH PFIC: DATA FROM THE MARCH/MARCH-ON TRIALS | Tony Tokman |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-51 | IMPROVEMENTS IN PRURITUS ARE ASSOCIATED WITH IMPROVEMENTS IN GROWTH IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DATA FROM THE MARCH-ON TRIAL | Tony Tokman |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-52 | CLINICAL UTILITY OF COMPREHENSIVE GENETIC TESTING IN ADULT CHOLESTASIS: INSIGHTS FROM 856 PANEL TESTS | Tony Tokman |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-53 | COMPREHENSIVE ANALYSIS OF CHOLESTASIS GENETIC PANEL RESULTS FROM 2016 TO 2022 IN CHILDREN AND YOUNG ADULTS: INSIGHTS INTO DIAGNOSTIC YIELD | Tony Tokman |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-77 | THAPSIGARGIN INHIBITS HEPATITIS C VIRUS INFECTION THROUGH THE INDUCTION OF ENLARGED LIPID DROPLETS | Trinity Tooley-Macarandang |
| CDDW | Clinical Practice | A102 | GENDER-SPECIFIC BARRIERS IMPACTING THE GASTROENTEROLOGY TRAINING JOURNEY: A SCOPING REVIEW | Hiu-Ki Tran |
| CDDW | Clinical Practice | A125 | THE ROLE OF IMMIGRATION STATUS IN GASTROENTEROLOGY REFERRALS | Hiu-Ki Tran |
| CDDW | Clinical Practice | A111 | NURSE-LED TARGET-CONTROLLED INFUSION OF PROPOFOL FOR ENDOSCOPY: A PILOT STUDY | Catherine Tsai |
| CDDW | Gastrointestinal Oncology | A170 | SAFETY AND PROFICIENCY OF ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) – A 5-YEAR CANADIAN TERTIARY CENTRE SINGLE-OPERATOR EXPERIENCE | Catherine Tsai |
| CDDW | Cellular & Molecular Gastroenterology | A32 | _x000D_
NOD2 DRIVES REGENERATIVE FETAL-LIKE REPROGRAMMING IN THE INTESTINAL EPITHELIUM | Derek Tsang |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A276 | ENDOTHELIAL-INTRINSIC NOD2 SIGNALLING CONTROLS INTESTINAL EFFECTOR AND MEMORY T CELL GENERATION | Boyan Tsankov |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-62 | DIAGNOSIS AND TREATMENT OF BILIARY CAST SYNDROME: A SYSTEMATIC REVIEW | RalphJustin Uy |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A264 | HIGH RISK OF COLORECTAL CANCER AFTER COLONIC HIGH-GRADE DYSPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | Lierop, van |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-95 | FROM BLAME TO BELONGING: APPLYING AN “OVERCOMING OTHERING” LENS TO HEPATITIS C COMMUNICATIONS IN CANADA | Jennifer vanGennip |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-83 | WILSON DISEASE IN A VERY YOUNG CHILD: EXPANDING THE AGE SPECTRUM OF AN INHERITED DISORDER OF COPPER METABOLISM | Andrea VasconezMontalvo |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-028 | PRE-OPERATIVE TIPS DECREASES THE RATE OF POST-OPERATIVE CLINICAL BLEEDING AND ASCITES IN PATIENTS WITH CIRRHOSIS UNDERGOING NON-TRANSPLANT SURGERY: A RETROSPECTIVE SINGLE CENTRE CANADIAN STUDY | Ali Vedadi |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A251 | REAL-WORLD EFFECTIVENESS, SAFETY, AND DOSE MODIFICATIONS OF UPADACITINIB IN PATIENTS WITH CROHN'S DISEASE: A CANADIAN MULTICENTER STUDY | Lisa Van Lierop |
| CDDW | Clinical Practice | A107 | CHOOSING WISELY: THE NEW AND IMPROVED PPI TOOLKIT: ASK WHY FOR PPIS | Sander Veldhuyzen Van Zanten |
| CDDW | Endoscopy, Technology & Imaging | A55 | PERFORMANCE OF LARGE LANGUAGE MODELS IN THE OPTICAL DIAGNOSIS OF COLORECTAL POLYPS | Joshua Vences |
| CDDW | Neurogastroenterology & Motility | A320 | BIOACTIVE PHOSPHOLIPIDS AS MEDIATORS OF ALTERED BEHAVIOUR AND VISCERAL HYPERSENSITIVITY ASSOCIATED WITH MICROBIOTA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) | Fernando Vicentini |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-91 | PATIENT REPORTED OUTCOMES AND QUALITY OF LIFE MEASURES AFTER HEPATITIS B SURFACE ANTIGEN LOSS | Jordyn Vienneau |
| CDDW | Cellular & Molecular Gastroenterology | A33 | HYMENOLEPIS DIMINUTA-DERIVED EXTRACELLULAR VESICLES UPREGULATE A REGULATORY PHENOTYPE IN MURINE MACROPHAGES AND PROMOTE INTERACTION WITH T CELLS | Parker Volk |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A310 | CROHN'S DISEASE OF THE POUCH: A RETROSPECTIVE CASE SERIES FROM A CANADIAN TERTIARY CENTRE | Arpana Wadhwani |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-122 | REAL-WORLD IMPACT OF FIBROSIS SEVERITY ON ACTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS IN CANADA | Hayley Wallinger |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-123 | REAL-WORLD IMPACT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS AND ADDITIONAL CARDIOMETABOLIC AND RENAL COMORBIDITIES ON CLINICAL BURDEN AND HEALTHCARE RESOURCE UTILIZATION IN CANADA | Hayley Wallinger |
| CDDW | Clinical Practice | A121 | DEVELOPMENT OF A COMMUNICATIONS CURRICULUM FOR GASTROENTEROLOGY TRAINEES: A PILOT STUDY | Grace Wang |
| CDDW | Gastrointestinal Oncology | A161 | G0S2 PROTEIN REGULATES COLON INFLAMMATION AND COLORECTAL CANCER THROUGH PRODUCTION OF BRANCHED-CHAIN FATTY ACIDS | Yilin Wang |
| CDDW | Endoscopy, Technology & Imaging | A69 | IMAGE-ENHANCED ENDOSCOPY VERSUS WHITE-LIGHT IMAGING FOR DETECTING EARLY GASTRIC CANCERS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Jun Watanabe |
| CDDW | Neurogastroenterology & Motility | A338 | EVALUATING THE QUALITY OF IBS-RELATED CONTENT ACROSS MAJOR SOCIAL MEDIA PLATFORMS: A CROSS-SECTIONAL STUDY | Sabrina Watson |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A266 | ARTIFICIAL INTELLIGENCE IN IBD: CURRENT EVIDENCE AND EMERGING APPLICATIONS | Aaron Wen |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-120 | SEX-SPECIFIC SURVIVAL PHENOTYPES INFORMED BY CLINICAL, SOCIAL, AND LIFESTYLE FACTORS: TOWARDS A PERSON-CENTRED PROGNOSIS OF STEATOTIC LIVER DISEASE | Cindy Wen |
| CDDW | Neurogastroenterology & Motility | A329 | EVALUATING THE IMPACT OF INCLUDING DIETARY EDUCATION WITHIN AN ELECTRONIC IRRITABLE BOWEL SYNDROME PATHWAY | Natalie Willett |
| CDDW | Neurogastroenterology & Motility | A335 | IMPLEMENTATION EFFECTIVENESS OF MINDFULNESS INTERVENTIONS IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW | Natalie Willett |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A272 | EVOLUTION OF UC:CD INCIDENCE RATIOS ACROSS EPIDMIOLOGIC STAGES | Joseph Windsor |
| CDDW | Gastrointestinal Oncology | A179 | SYSTEMATIC REVIEW OF GASTRIC POLYP OUTLET OBSTRUCTION: DIAGNOSIS AND MANAGEMENT | Michael Sangwook Woo |
| CDDW | Liver | A182 | REVERSE HEPATITIS B SEROCONVERSION WITHOUT IMMUNOSUPPRESION: A CASE REPORT | Eric Wu |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A244 | PERINATAL NUTRIENT CONSUMPTION DIFFERS IN PREGNANT WOMEN WITH AND WITHOUT INFLAMMATORY BOWEL DISEASES | Karren Xiao |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-145 | PATIENTS WITH MASLD DECOMPENSATE AT A LOWER HEPATIC VENOUS PRESSURE GRADIENT THRESHOLD: DATA FROM A CANADIAN MULTICENTRIC RETROSPECTIVE COHORT STUDY | XiaoYu Xie |
| CDDW | Liver | A186 | EVOLVING OUTCOMES AFTER LIVER TRANSPLANTATION (LT) FOR ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): AN ERA ANALYSIS OF DONATION AFTER CIRCULATORY DEATH (DCD) VS DONATION AFTER BRAIN DEATH (DBD) GRAFTS | Yvette Ysabel Yao |
| CDDW | Liver | A187 | IMPACT OF TRANSFER TIMING ON LIVER TRANSPLANT OUTCOMES: A SINGLE-CENTER COHORT STUDY | Yvette Ysabel Yao |
| CDDW | Endoscopy, Technology & Imaging | A59 | TEMPORAL TRENDS IN ADHERENCE TO QUALITY INDICATORS IN ENDOSCOPIC SURVEILLANCE OF BARRETT’S ESOPHAGUS | Yvette Ysabel Yao |
| CDDW | Gastrointestinal Oncology | A160 | ROLE OF PREPROCEDURAL BIOPSIES IN LOWER GASTROINTESTINAL TUMORS UNDERGOING ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) AND IMPACT ON FIBROSIS AND RESECTION RATES | Michael Youssef |
| CDDW | Gastrointestinal Oncology | A167 | ROLE OF PREPROCEDURAL BIOPSIES IN UPPER GASTROINTESTINAL TUMORS UNDERGOING ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) AND IMPACT ON FIBROSIS AND RESECTION RATES | Michael Youssef |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A309 | DIETARY QUALITY, FOOD SECURITY, AND PSYCHOSOCIAL DETERMINANTS IN ADULTS WITH INFLAMMATORY BOWEL DISEASE: INSIGHTS FROM THE MCMASTER IBD NUTRITION REGISTRY | Hani Zafar |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A236 | PSYCHOLOGICAL STRESS IMPAIRS MUCOSAL GUT BARRIER INTEGRITY AND LEADS TO LOSS OF HOST CONTROL OF CROHN'S DISEASE-ASSOCIATED ADHERENT-INVASIVE E. COLI | Megan Zangara |
| CDDW | Clinical Practice | A105 | DETERMINING A BENCHMARK FOR THE ST.PAUL'S ENDOSCOPIC COMFORT SCALE (SPECS) | Aein Zarrin |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A215 | ASSOCIATION BETWEEN CROHN'S DISEASE POLYGENIC RISK SCORE AND GUT MICROBIOME IN HEALTHY FIRST-DEGREE RELATIVES | Stamatis Zezos |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-55 | MELD 3.0 AND SEX DIFFERENCES IN LIVER TRANSPLANT PATIENTS: A SINGLE CANADIAN COHORT STUDY | Yixuan Zhao |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A303 | RISK FACTORS FOR THE DEVELOPMENT AND PROGRESSION OF PERIANAL CROHN'S DISEASE: A SYSTEMATIC REVIEW | Jamie Zhen |
| CDDW | Gastrointestinal Oncology | A158 | DIAGNOSTIC PERFORMANCE OF ENDOSCOPIC ULTRASOUND FOR GASTRIC CANCER STAGING: A SYSTEMATIC REVIEW AND META-ANALYSIS | Katina Zheng |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-40 | TIPS AS A TREATMENT FOR COMPLICATIONS OF PORTAL HYPERTENSION IN CIRRHOSIS – THE EXPERIENCE FROM TORONTO GENERAL HOSPITAL | Katina Zheng |
| CLM | MASLD/MASH - Clinical Science, Epidemiology & Public Health | P-131 | HIGH PREVALENCE OF MASLD AND SEVERE STEATOSIS AMONG NON-OBESE FILIPINO INDIVIDUALS IN BRITISH COLUMBIA | Kai Zhu |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-80 | UTILITY OF HCV DRUG RESISTANCE PROFILES TO DISTINGUISH RELAPSES FROM REINFECTIONS | Andy Zhu |
| CDDW | Endoscopy, Technology & Imaging | A52 | THE USE OF LARGE LANGUAGE MODELS IN GASTROENTEROLOGY LITERATURE: A GROWING ARTIFICIAL INTELLIGENCE FOOTPRINT | Amine Zoughlami |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-70 | GENERATION OF A STABLE WOODCHUCK HEPATITIS VIRUS (WHV) REPLICATION MODEL TO STUDY HEPADNAVIRAL REPLICATION AND PERSISTENCE | Kruthika Iyer |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A222 | INVESTIGATING INFLAMMATORY BOWEL DISEASE (IBD) THROUGH THE LENS OF AUTOPHAGY AND MITOCHONDRIA | Amit Jaiswal |
| CDDW | Endoscopy, Technology & Imaging | A64 | ENHANCING INFORMED CONSENT: A SYSTEMATIC REVIEW AND META-ANALYSIS OF VIDEO- AND COMPUTER-BASED APPROACHES COMPARED WITH CONVENTIONAL METHODS | Imran Jamal |
| CDDW | Neurogastroenterology & Motility | A337 | GASTROINTESTINAL MOTILITY IN CANNABIS USERS: A WIRELESS MOTILITY CAPSULE INVESTIGATION | Darius Javidi |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-71 | EPIGENETIC LANDSCAPE OF CENTRAL MEMORY T CELLS IS SKEWED BY PREEXISTING CHRONIC INFECTION | Mohamed Abdelhakeem |
| CLM | Viral Hepatitis - Biomedical, Translational & Basic Science | P-72 | PHOSPHOPROTEOMIC PROFILING OF EXHAUSTED T CELLS IDENTIFIES EXHAUSTION-SPECIFIC KINASES AS NOVEL IMMUNOTHERAPEUTIC TARGETS | Mohamed Abdelhakeem |
| CDDW | Gastrointestinal Oncology | A169 | COMPARATIVE OUTCOMES OF EMR AND ESD FOR BARRETT'S NEOPLASIA | Hussain Abdulhussain |
| CDDW | Clinical Practice | A104 | INSIGHTS ON A NURSE NAVIGATOR INTERVENTION FOR INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE LIVING IN RURAL COMMUNITIES: A STUDY FROM SASKATCHEWAN, CANADA | Nisha Adhikari |
| CDDW | Clinical Practice | A146 | VILLAGE TO VISCERA: EVALUATING THE EFFECT OF SOCIAL SUPPORT ON INFLAMMATORY BOWEL DISEASE MANAGEMENT | Rubia Ahmed |
| CDDW | Clinical Practice | A150 | A RARE CASE OF PARTIAL SMALL BOWEL OBSTRUCTION FROM PHYTOBEZOAR MIMICKING CROHN’S DISEASE FLARE | Rubia Ahmed |
| CDDW | Clinical Practice | A155 | RUPTURE AT THE SHORELINE: FLOOD SYNDROME WITH SPONTANEOUS EVISCERATION | Rubia Ahmed |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A204 | EXPERIENCE FROM A SINGLE-CENTRE MULTIDISCIPLINARY EOE CLINIC | Nabeel Ahmed |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A206 | AT-HOME BREATH ANALYSIS TO UNCOVER DIETARY TRIGGERS IN IBD: A NEW FRONTIER FOR PERSONALIZED SYMPTOM MANAGEMENT | Anam Ahmed |
| CDDW | Neurogastroenterology & Motility | A333 | ARTIFICIAL INTELLIGENCE MODELS DEMONSTRATE PROMISING BUT SUBOPTIMAL PERFORMANCE IN DIAGNOSING AND TREATING DISORDERS OF GUT-BRAIN INTERACTION | Matthew Ahn |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A218 | BUTYRATE’S ROLE IN MODULATING TIGHT JUNCTIONS, GPR41/43 RECEPTORS, AND IMMUNOGLOBULIN RESPONSES IN EXPERIMENTAL COLITIS | Fazia Ait Zenati |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A232 | AZATHIOPRINE DOSE THRESHOLD IN ANTI TNF COMBINATION THERAPY FOR MINIMIZING IMMUNOGENICITY IN IBD: A RETROSPECTIVE COHORT STUDY | Nourah Alajeel |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A224 | ACQUIRED HEMOPHILIA A IN AN ADOLESCENT WITH ULCERATIVE COLITIS ON INFLIXIMAB: A CASE REPORT | Abdulaziz Alammar |
| CDDW | Clinical Practice | A101 | HOW SOON IS NECESSARY? A SYSTEMATIC REVIEW & META-ANALYSIS OF SURVEILLANCE INTERVALS AFTER RESECTION OF ≥3 NON-ADVANCED ADENOMAS | Hamdan AlAwadhi |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A258 | THE ROLE OF BACTERIAL LPC AND LPA IN CHRONIC ABDOMINAL PAIN: _x000D_
A LONGITUDINAL STUDY IN PATIENTS WITH IBD | Jumanah Alawfi |
| CDDW | Endoscopy, Technology & Imaging | A48 | DIGITAL MICROSCOPY IN THE ENDOSCOPY SUITE: A REFERENCE STANDARD FOR COLORECTAL POLYP SIZE MEASUREMENT | Preslava Aleksieva |
| CDDW | Endoscopy, Technology & Imaging | A76 | TO EUS OR NOT? EVALUATING THE NECESSITY OF ENDOSCOPIC ULTRASOUND IN UNEXPLAINED BILIARY DUCT DILATION WITH NORMAL LIVER FUNCTION TESTS: A COMPREHENSIVE SYSTEMATIC REVIEW | Zainab Alfaraj |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A265 | IL23R GENE POLYMORPHISM AS A PREDICTOR OF RESPONSE TO USTEKINUMAB (STELARA) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE | Zaki Alhashimalsayed |
| CDDW | Intestinal Disorder | A82 | VIP-SECRETING NEUROBLASTOMA AS A RARE CAUSE OF PERSISTENT SECRETORY DIARRHEA IN INFANCY | Azzam Aljaafari |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A274 | TWSG1 VARIATION IDENTIFIES A USTEKINUMAB-RESPONSE PHENOTYPE IN PAITNETS WITH INFLAMMATORY BOWEL DISEASE | Mohammed Alkhalifa |
| CLM | Other liver disease - Clinical Science, Epidemiology & Public Health | P-147 | UNCOMMON ARTERIAL ANOMALIES IN A PATIENT WITH VISCERAL AVMS AND NEGATIVE GENETIC TESTING: AN ATYPICAL CASE OF POSSIBLE HEREDITARY HEMORRHAGIC TELANGIECTASIA | Nayef Alkhalil |
| CDDW | Esophageal, Gastric & Duodenal Disorders | A197 | LONG-TERM DUPILUMAB MAINTAINS HISTOLOGIC AND ENDOSCOPIC IMPROVEMENTS IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS (EOE): 100-WEEK DATA FROM THE OPEN-LABEL EXTENSION (OLE) OF THE EOE KIDS STUDY | Rami AlKhouri |
| CDDW | Neurogastroenterology & Motility | A334 | PATTERNS AND DIAGNOSTIC YIELD OF ESOPHAGEAL MOTILITY DISORDERS: A RETROSPECTIVE HIGH-RESOLUTION MOTILITY STUDY | Saleh Alobaid |
| CDDW | Cellular & Molecular Gastroenterology | A38 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME (MMIHS): A RARE CASE WITH FULL CLINICAL EXPRESSION | Salem Alobaidan |
| CDDW | Clinical Practice | A152 | IMPROVING ACCESS TO OUTPATIENT THERAPEUTIC PARACENTESIS: A QUALITY IMPROVEMENT APPROACH TO MINIMIZE MISSED SLOTS AND EMERGENCY DEPARTMENT RELIANCE. | Khalid Alseiari |
| CDDW | Neurogastroenterology & Motility | A336 | FLNA DEFICIENCY PRESENTING AS INTESTINAL PSEUDO-OBSTRUCTION IN INFANCY: A CASE REPORT AND LITERATURE REVIEW. | Wejdan Alrasheed |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A273 | NON-ANTI-TNF ADVANCED THERAPEIS FOR THE MANAGEMENT OF ORAL CROHN'S DISEASE: A CASE SERIES | Khalid Alseiari |
| CDDW | Clinical Practice | A154 | HEALTH-RELATED QUALITY OF LIFE IN JORDANIAN CHILDREN WITH FUNCTIONAL AND ORGANIC GASTROINTESTINAL DISORDERS: A CROSS-SECTIONAL STUDY USING THE ARABIC KIDSCREEN-52 | Eyad Altamimi |
| CDDW | Liver | A183 | DIAGNOSTIC AND THERAPEUTIC UTILITY OF LIVER BIOPSY IN CHILDREN: A SINGLE-CENTER RETROSPECTIVE STUDY | Eyad Altamimi |
| CDDW | Endoscopy, Technology & Imaging | A68 | VALIDATION OF THE SAURIN CLASSIFICATION IN A NORTH AMERICAN PATIENT COHORT UNDERGOING VIDEO CAPSULE AND ENTEROSCOPY FOR OBSCURE BLEEDING | Naik Arbabzada |
| CLM | Viral Hepatitis - Clinical Science, Epidemiology & Public Health | P-106 | HEPATITIS B VIRUS GENOTYPE DISTRIBUTION AND SOCIODEMOGRAPHIC PROFILES IN AN IMMIGRATION-DRIVEN CANADIAN COHORT | Welde Aregawi |
| CDDW | Inflammatory Bowel Diseases: Mechanisms and Treatments | A300 | BARRIERS TO MESALAMINE ADHERENCE IN PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: A QUALITATIVE SYSTEMATIC REVIEW | Ibreez Asaria |
| CDDW | Gastrointestinal Oncology | A171 | OUTCOMES OF ENDOSCOPIC MUCOSAL RESECTION OF LARGE COLORECTAL POLYPS REFERRED TO A SINGLE TERTIARY CENTRE | Narges Ashrafinia |
| CDDW | Endoscopy, Technology & Imaging | A71 | ENDOSCOPIC ULTRASOUND-GUIDED THROMBIN INJECTION, A NOVEL THERAPY, IN A CHALLENGING CASE OF PANCREATIC PSEUDOANEURYSM | Narges Ashrafinia |
| CDDW | Clinical Practice | A122 | VACCINATION UPTAKE IN IBD PATIENTS COMMENCING BIOLOGIC TREATMENT: A QUALITY IMPROVEMENT PROJECT | Syed Anam Asim |
| Thursday, February 26, 2026 |
|---|
| | | | CAG - Board of Directors | |
| | | | Specialty Committee in Gastroenterology | |
| Friday, February 27, 2026 |
|---|
| | | | CASL Trainee & New Members Happy Hour | |
| | | | Opening and Award Ceremonies | |
| | | | LUNCH | |
| | | | CAG - Clinical Affairs | |
| | | | CAG - Research Affairs | |
| | | | Workshop - Intestinal Ultrasound Hands on Session AM | |
| | | | Special Event - Gut Instincts: Women Driving Entrepreneurship in GI and Hepatology - A fireside chat with women gastroenterologists making a difference in the business world | |
| | | | Diagnostics | |
| | | | Best Clinical Research Abstracts | |
| | | | Prospects for Prevention & Elimination | |
| | | | MORNING COFFEE | |
| | | | CAG - Advocacy Committee | |
| | | | Perspectives from the frontlines on prevention | |
| | | | Bleeding Edge: Beyond the Usual Suspects - CAG guidelines on the endoscopic management of non-variceal non-peptic ulcer bleeding | |
| | | | Public Health and Policy | |
| | | | CAG - Nutrition | |
| | | | Adverse reactions to foods in chronic intestinal disorders | |
| | | | CAG - CANMO | |
| | | | Mentorship Cafe | |
| | | | CLM LUNCH SYMPOSIUM | |
| | | | CAG - JCAG Editorial Board | |
| | | | CLM Award Ceremony & Gold Medal Lecture | |
| | | | JCAG Symposium - The Skinny on GLP-1 Receptor Agonists in Gastrointestinal Diseases | |
| | | | Live Endoscopy 1 - Luminal | |
| | | | CDDW™ BREAKFAST SYMPOSIUM | |
| | | | CLM LUNCH SYMPOSIUM | |
| | | | CDDW™ LUNCH SYMPOSIUM | |
| | | | Opening & Epidemiology and Natural History | |
| | | | PM BREAK | |
| | | | AM BREAK | |
| | | | Liver Transplantation | |
| | | | Live Endoscopy 2 - Pancreaticobiliary | |
| | | | EDIRA Symposium - Cultural Competency in Gastroenterology | |
| | | | Novel perspectives on targets and Drug delivery GI diseases | |
| | | | Special Event - Award Lectures | |
| | | | Advancing IBD Care in a Public System: Precision, Innovation, and Therapeutic Optimization | |
| | | | CDDW™ LUNCH SYMPOSIUM | |
| | | | Workshop - Intestinal Ultrasound Hands on Session PM | |
| | | | Viral Hepatitides | |
| | | | Contemporary Directions in Hepatology: Core Concepts for the Gastroenterology Post-Graduate | |
| | | | CASL - CanMASLD | |
| | | | Fibroscan Workshop 1 | |
| | | | Early Onset Colorectal Cancer Rethinking Risk, Responsibility, and Screening | |
| | | | AM BREAK | |
| | | | PM BREAK | |
| | | | Best Research Abstracts | |
| | | | Poster Session I & Opening Reception | |
| | | | Prevention in Priority Populations | |
| Saturday, February 28, 2026 |
|---|
| | | | CASL HERhepato Evening Reception | |
| | | | CASL - Pediatrics | |
| | | | Mentorship Cafe | |
| | | | CASL Morning Rounds: Meet the Experts Session | |
| | | | CASL - ALD | |
| | | | CASL - Complications from Cirrhosis | |
| | | | PM BREAK | |
| | | | Vaccines and Host Responses to Infection | |
| | | | The upper GI in focus: From bench to bedside | |
| | | | Parlons foie: session francophone | |
| | | | Perspectives on HCV CHIM & Vaccines | |
| | | | Future Directions in Alcohol-Associated Liver Disease: From Biology to Policy | |
| | | | Kopelman Lecture | |
| | | | Therapeutics | |
| | | | Changing landscape of nutrition in IBD and celiac disease: Obesity, body composition and GLP-1s | |
| | | | Pediatric Hepatology | |
| | | | CAG - SEE Committee and Faculty | |
| | | | CAG - Education Affairs | |
| | | | CDDW GI Mapping | |
| | | | NASPGHAN Symposium - Food as Medicine: The Best Prescription for GI Health? | |
| | | | Presidents' Gala Reception & Dinner | |
| | | | Update on Bloating Management | |
| | | | CDDW™ BREAKFAST SYMPOSIUM | |
| | | | Fibroscan Workshop 2 | |
| | | | MORNING COFFEE | |
| | | | AM BREAK | |
| | | | PM BREAK | |
| | | | LUNCH | |
| | | | CLM LUNCH SYMPOSIUM | |
| | | | Special Event - McKenna Lecture | |
| | | | The influence of non-bacterial microbiota on gut function | |
| | | | Poster Session II | |
| | | | Cage Matches | |
| | | | The Inner Frontier: Host Defensive Barriers in the Gut | |
| | | | Immune-Mediated and Cholestatic Liver Diseases | |
| | | | Advancing Quantitative HBsAg Diagnostic Testing Through Cross-Disciplinary Collaboration: Insights From Medical Microbiology, Infectious Diseases, and Hepatology | |
| | | | CDDW™ LUNCH SYMPOSIUM | |
| | | | Bridging Borders: Integrating 2025 U.S. Neurogastroenterology Guidelines into Canadian Clinical Practice | |
| | | | CDDW™ LUNCH SYMPOSIUM | |
| | | | AM BREAK | |
| | | | CAG - Administrative Affairs | |
| | | | CAG - Practice Affairs | |
| | | | CAG - Quality Affairs | |
| | | | CLM LUNCH SYMPOSIUM | |
| | | | CASL Annual General Meeting (AGM) | |
| | | | Joint CDDW™-CLM Symposium - MASLD: Luminal vs Hepatological Concerns | |
| Sunday, March 1, 2026 |
|---|
| | | | MORNING COFFEE | |
| | | | CASL - Transplant | |
| | | | CASL - CaNAL | |
| | | | CASL - CanHepB Network | |
| | | | Gastrointestinal Endoscopy – Moving to Environmental and Financial Sustainability | |
| | | | Psychiatric comorbidities of GI diseases | |
| | | | CAG - Endoscopy Reporting | |
| | | | CAG - C-GRS | |
| | | | CAG - Climate Change Committee | |
| | | | Public Health Policies and Interventions in Chronic Liver Disease | |
| | | | Basic Science/Research | |
| | | | AM BREAK | |
| | | | Dysphagia – it is esophageal, oropharyngeal or both? | |
| | | | Oral Abstract Presentations | |
| | | | How to build linkages and programs for vulnerable communities affected by liver disease | |
| | | | Small intestine: the black box of the GI tract | |
| | | | AM BREAK | |
